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ABSTRACT 
The effect of megadoses of vitamin B12 , folate, and vitamin Con 
the in vivo methylation of mercurfc chloride was studied in guinea pigs. 
The incorporation of high levels of vitamin B12 , folate, and vitamin C 
resulted in a decrease in both inorganic mercury and methylmercury 
concentrations in all tissues except the lung and heart compared to 
controls. However, percent methylmercury levels tended to increase with 
vitamin treatment. 
The addition of megadoses of vitamin B12 fed either singularly or 
in combination with the other vitamins resulted in increased 
methylmercury concentrations in the liver, spleen, and kidney tissues of 
the guinea pig. Moreover, percent methylmercury levels increased with 
B12 treatment in the liver, heart, and kidney. Incorporation of high 
levels of folate into the dietary regime also affected the mercury 
methylation process particularly in the liver, heart, kidney and hair 
tissues. However, this effect was observed most often in animals fed 
both B12 and folate. Vitamin C appears to play a synergistic role with 
vitamin B12 and/or folate in the methylation of mercury. 
Auditory brainstem responses (ABR) produced results which 
supported the theory that vitamin B12 treatment can potentiate the 
mercury effect in the auditory pathways of the guinea pig. Wave 
latencies were longer and threshold values were higher in animals fed 
megadoses of B12 • Interpeak latency means were also longer in animals 
treated with vitamins and mercury compared to untreated controls. 
V 
Rats fed diets supplemented with either methionine or cysteine 
exhibited differences in methylmercury levels. Both methionine and 
cysteine supplementation resulted in a significant increase in percent 
methylmercury levels in the liver and kidney. 
These data indicate that megadoses of vitamin 812 , folate, and/or 
vitamin C may alter the methylation process of mercury in vivo. In 
addition, methionine or cysteine supplementation can effect the 
metabolism of mercuric chloride possibly via transmethylation processes. 
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CHAPTER I 
INTRODUCTION 
Mercury has been recognized as a hazardous environmental pollutant 
since the outbreak of mercury poisoning in Minamata Bay, Japan, in the 
1950's. People were poisoned as a result of consuming fish which had 
acquired high concentrations of methylmercury due to contamination of 
local waters with industrial waste (1,2). Mass poisonings were reported 
in Iraq during 1971-72 (3). Grain which was treated with mercurial seed 
dressings was issued to Iraq farmers in 1956 and 1960 for planting but 
economic conditions resulted in its improper use as food (3,4). Several 
outbreaks of poisoning due to the use of treated seeds for food were 
subsequently reported (2,4,5). 
Despite these events, mercury is still widely used in the 
production of certain chemicals, fungicides, insecticides, paints, and 
electrical equipment (6,7). In addition, many industrial waste products 
contain mercury and are discarded in oceans, rivers, lakes, and 
landfills (6,7). A more recent concern is the level of mercury exposure 
as a result of dental amalgams. Thus, the general public continues to 
be exposed to mercury from a number of rather widespread sources. As a 
result, many toxicological studies have been conducted to explain the 
distribution, mode and site of action and elimination of mercury in 
animals. 
Mercury is toxic in either the metallic or divalent form; however, 
the chemical form and dose alters the selection of the target organ (7). 
It has long been known that mercury and its organic form, methylmercury, 
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are neurotoxic. Although there have been a large number of neurological 
studies conducted using animal models, only a few have explored the 
visual and otological deficits caused by mercury. 
Methylmercury has been shown to be highly toxic to mammalian 
systems. The biological formation of methylmercury requires the 
coenzyme methyl-cobalamine (vitamin B12} (8). Additionally, it is 
logical to assume that the regeneration of methyl-cobalamine would 
require one of the forms of tetrahydrofolate (folacin} (9). Therefore, 
it appears conceivable that individuals who consume megadoses of these 
vitamins, B12 and folacin, would increase their potential to form 
methylmercury. It has also been shown that the addition of ascorbic 
acid to an incubation mixture enhances methylmercury-induced lipid 
peroxidation in the mitochondria (10). Additionally, studies have shown 
that ingestion of megadoses of vitamin C with other vitamins permits 
increases in the level of metabolically active cobalamin (vitamin B12 } 
as well as other vitamins (11). The purpose of this investigation was 
to examine if there is a relationship between consumption of 
megavitamins and mercury retention and metabolism. 
Research Hypothesis 
Since this project consisted of three distinct investigations, 
there were three separate research questions: 
1) Ho: The ingestion of megadoses of vitamin B12 , fol ate, or 
ascorbic acid will not result in increased methylation and 
retention of mercury as methylmercury in the liver, heart, 
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spleen, kidneys, brain, muscle, lungs, blood or hair of the 
guinea pig. 
Ha: The ingestion of megadoses of vitamin B12 , folate, or 
ascorbic acid will result in increased methylation and 
retention of mercury as methylmercury in the liver, heart, 
spleen, kidneys, brain, muscle, lungs, blood or hair of the 
guinea pig. 
2) Ho: A casein-based diet supplemented with methionine or 
cysteine will not result in increased methylation and 
retention of mercury as methylmercury in the liver, heart, 
spleen, kidneys, brain or lungs of rats. 
Ha: A casein-based diet supplemented with methionine or 
cysteine will result in increased methylation and retention 
of mercury as methylmercury in the liver, heart, spleen, 
kidneys, brain or lungs of rats. 
3) Ho: A diet containing megadoses of vitamin B12 , folate, or 
ascorbic acid will not effect mercury metabolism in guinea 
pigs as demonstrated by altered auditory brainstem responses. 
Ha: A diet containing megadoses of vitamin B12 , folate, or 
ascorbic acid will effect mercury metabolism in guinea pigs 
as demonstrated by altered auditory brainstem responses. 
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CHAPTER II 
REVIEW OF LITERATURE 
Mercury Assessment Measurements 
The best non-invasive indices of exposure to methylmercury are 
levels of mercury in hair and blood {12). Studies in Scandinavia on the 
metabolism of trace amounts of radiolabeled methylmercury by humans have 
shown that methylmercury is completely {more than 95%) absorbed from 
food and is rapidly distributed throughout the body. These studies also 
allowed calculation of the half-life of mercury in humans {about 70 
days) and provided information regarding the relative concentration of 
mercury in the various parts of the body {12). Additional studies have 
shown the relationship between ingestion of methylmercury from 
contaminated fish and mercury levels in the blood and hair {12). 
Blood measurements are of great diagnostic and prognostic 
significance because there is an equilibrium between tissue 
concentrations and blood level {13). However, the central nervous 
system {CNS) stands out as an exception to this. Both the brain and 
cerebellum may still contain significant amounts of methylmercury 
even several years following exposure and while the kidneys, liver, and 
blood have returned to normal values. Therefore, the CNS appears to 
accumulate methylmercury over much longer time spans than any other 
organ and consequently, the degree of concentration in the CNS is not 
reflected reliably by blood measurements {13). 
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Due to several unique properties, hair has gained a more important 
role in the assessment of both mercury exposure and body burden. First, 
hair contains a number of sulfhydryl groups which act as binding sites 
for mercury ions and radicals (13). As a general rule, the mercury 
concentration in hair is 250-300 times higher than that in blood. 
Therefore, the higher concentrations yield more reliable measurements 
(14). Secondly, since hair growth resembles ary extrusion process with a 
mean growth rate of 1 cm/month, analysis of segments (1 cm long) of hair 
can provide mean monthly blood concentrations of mercury throughout one 
year prior to sampling (13,14). 
Urine sampling has also been used as a method of determining 
inorganic mercury exposure. However, the mercury content of urine 
displays such wide individual variation, depending on fluid intake, type 
of food and many other factors, that it is impossible to derive any 
meaningful definition of normal values and any definite conclusions 
about the body burden (13). While the mercury content of urine yields 
little information about the body burden, it has occasionally been used 
as a diagnostic tool. For example, following a sudden and known 
ingestion of mercury salts, the urinary content serves as an indicator 
of uptake. Alternatively, when a patient is given treatment for removal 
of a high body burden of mercury, the urinary content will reflect 
tissue release of incorporated mercury and thus, the effectiveness of 
the therapy (13). 
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Health Risks 
In 1984, the United States Environmental Protection Agency (15) 
estimated that the average daily retention of mercury for the adult 
population was 153 nanograms per day for atmospheric Hg which is the 
predominant form of elemental mercury vapor. This is for the general 
population or one which is not occupationally exposed to the element. 
Retention of organomercurials mainly as methylmercury from fish was 
estimated at 3666 nanograms per day. Consumption of inorganic mercury 
compounds derived from nonfish dietary products was predicted to be 2000 
nanograms per day with 5 nanograms per day consumed in drinking water 
(15). 
However, it was suggested that these estimations should be 
considered highly provisional since their derivation was predicated on 
an approach totally at variance with the "real world" situation in which 
human beings are exposed simultaneously to many interacting 
environmental chemicals. In addition, these estimates are seriously 
influenced by such factors as degree of environmental pollution peculiar 
to each geographic zone, ambient temperature, humidity, sex, race, 
dietary habits, prevalence of disease and conditions of stress (15). 
Another important source of the human burden of mercury which was 
not considered in these estimations is the widespread daily use in some 
black communities, both in developed and third world countries, of 
depigmentation soaps and other cosmetic products which contain 3-5% 
mercuric salts. These mercuric salts, which are applied to the skin as 
ointments in suitable lipid vehicles, are readily absorbed and retained 
in the body (16). 
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In recent years, a number of articles (17,18,19) have indicated 
that fish consumption is beneficial in prevention of cardiovascular 
disease. However, studies have also shown that fish contaminated by 
mercury spills, particularly methylmercury, can present a potential 
human health hazard. 
A recent study was conducted by the Food and Drug Administration 
(FDA) (12) to evaluate fish consumption in the United States and 
calculate possible exposure to methylmercury. A consumption study which 
was commissioned by the Tuna Research Foundation in 1973-74 was used to 
determine the intake of fish and shellfish in the U.S. The average 
consumption of total seafood per individual was 18.58 ounces per month 
or approximately 18 g/day with 61.5% of the individuals sampled eating 
tuna. Mercury residue levels in domestic fish sampled by the FDA were 
then used to calculate the level of exposure to methylmercury. 
According to OSHA, the maximum permissible exposure limit for mercury is 
0.1 mg/m3 and the threshold value for organic compounds is 0.001 ppm 
(20). At this level, the U.S. fish consumption data did not indicate 
any cause for concern of methylmercury poisoning for the average 
American (12). 
However, studies conducted in other countries have shown slightly 
different results. A human metabolic study done in Japan examined the 
intake of tuna in relation to mercury concentrations in human hair (21). 
It was clearly shown that an increase in the mercury concentration in 
the hair was approximately proportional to the amount of tuna flakes 
consumed. It was, thus, suggested that those populations consuming 
large quantities of fish should be monitored in order to prevent mercury 
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poisoning (21). However, a recent study (22) examining methylmercury 
exposure and mortality in Japan found that there was no appreciable 
difference in life expectancy in populations of methylmercury-exposed 
areas as compared to control areas. However, the authors suggested that 
further investigation was needed to provide more insight into the 
delayed effect of methylmercury exposure on human health (22). 
A study done by Mason in 1987 surveyed the mercury content of eel 
and roach taken from 67 sites in Great Britain (23). On the average, 
eels contained significantly more mercury than roach. It was also 
determined that concentrations of metals in eels may more closely 
reflect environmental levels and could possibly be used as an indicator 
species. Twenty-five percent of the eels sampled exceeded recommended 
standards for human consumption. While freshwater fish do not figure 
much into.the diet of most Britons, there is a growing export of eels to 
mainland Europe and, therefore, it may be advisable to initiate a 
program of monitoring freshwater fish for heavy metals (23). 
Dermelj et al. (24) measured the levels of mercury, methylmercury, 
and selenium in scalp hair of populations from Mediterranean areas. 
Populations which consumed minimal amounts of seafood had very low 
concentrations of total mercury and methylmercury and a high ratio of 
mercury to methylmercury. However, populations from Yugoslav and the 
Greek coastal areas had elevated mercury levels in scalp hair with most 
of the mercury as methylmercury. This population had a high consumption 
of fish, shellfish, and other edible sea products. This study indicated 
that the elevated concentration levels of mercury in the scalp hair of 
these populations can be "directly attributed to the higher consumption" 
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of seafood products (24). This concept has been supported by research 
done in New Guinea (25), the United Kingdom (26), and Spain (27). 
Another concern that has been investigated recently is the level of 
mercury exposure which may result from dental amalgams, particularly 
among dental professionals. Silver-amalgam is still the cheapest, most 
durable, and most extensively used restorative material in dentistry for 
repair of decayed posterior teeth. Mercury accounts for about 50% of 
this alloy by weight (16). Sources of mercury exposure which exist in a 
dental office include accidental spills, poor mercury hygiene, manual 
mulling to express excess mercury from freshly mixed amalgam, mechanical 
amalgamators, ultrasonic amalgam condensors, failure to use high-vacuum 
suction while removing old amalgam restorations and improper dry heat 
sterilization of amalgam-contaminated instruments (28). 
A recent comprehensive assessment of the magnitude of mercury 
exposure in 4,272 US dentists focused on urinary levels of mercury (28). 
Urinary mercury levels ranged from 0-556 µg/liter with a mean level of 
14.2 µg/liter. It was noted that urinary mercury levels were related to 
geographic location within the country, dental specialty, type of 
air-conditioning in the practice, duration of working hours, and, 
especially, number of amalgam restorations placed or removed weekly, 
years in a dental specialty, and years in the current office facility. 
For example, a four-fold increase in urinary mercury level was observed 
in general practioners compared to orthodonists, and more than 31% of 
the dentists with urinary mercury levels in excess of 50 µg/liter 
practiced more than 40 hours per week (28). These results were 
supported by a more recent study which showed a significantly higher 
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blood level of mercury in 205 practicing dentists compared to non-dental 
controls (29). 
One study also indicated that subjects with dental amalgams had 
unstimulated mercury vapor concentrations significantly higher than 
basal levels of control subjects with no amalgams (30). With chewing, 
these levels increased six-fold over unstimulated mercury levels, or a 
54-fold increase over levels observed in control subjects (31). 
Therefore, it has been concluded that dental amalgam mercury makes a 
major contribution to total daily dose levels. 
Site of Toxicity 
Studies have shown that inorganic mercury and methylmercury are 
distributed in the body at different sites. Mitsumori et al. (32) 
treated rats of both sexes with various levels of methylmercury 
chloride and determined that the hair had high levels of mercury, 
while subsequently lower levels were found in the kidney, blood, liver, 
and nervous tissues, respectively (32). Blood biochemical examinations 
revealed that cholesterol and urea nitrogen increased which may have 
indicated toxic renal damage. These researchers found sex differences 
in clinical signs, mortality, body weight, hematology and blood 
biochemistry within the treated groups (32). 
Thomas et al. (33) determined that the distribution of mercury is 
affected by the sex of the animal. Female Long-Evans rats were able to 
excrete organic mercury more rapidly than their male counterparts. In 
fact, whole body clearance of mercury was faster in females than in 
males. It was determined that female rats had significantly higher mean 
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percentages of the methylmercury dose located in the kidney and brain, 
while males had higher mean percentages of the dose in pelt and whole 
body (as organic or total mercury). A sexual difference was also shown 
in accumulation or retention of inorganic mercury in the nervous system. 
The reported sexual differences in methylmercury toxicity may be 
explained by these sexual differences in distribution and retention of 
organic and inorganic mercury following methylmercury exposure (33). 
Alexander and Aaseth (34) found that the organ distribution of 
mercury was altered with administration of cysteine or glutathione. A 
rapid uptake of mercury in the kidney and a depressed content in the 
liver and blood was observed in female rats given an intravenous 
injection of methylmercury chloride premixed with glutathione or 
cysteine as compared to animals given methylmercury alone. Following 
exposure to methylmercury, the physiological formation of a 
methylmercury-glutathione complex takes place mainly intracellularly. 
Since the liver has the ability to synthesize glutathione, it is a 
primary site for the conjugation of methylmercury and glutathione. 
Additionally, the liver cells are able to export large amounts of this 
complex into the bile which reduces the liver content of methylmercury. 
The addition of cysteine increases the amount of methylmercury binding 
since it probably increases the intracellular levels of glutathione. It 
was noted that this complex can be reabsorbed from the gut and is 
rapidly extracted from the blood plasma by the kidneys (34). 
A recent study by Atchison et al. (35) examined the effect of 
methylmercury at the nerve terminals. It has been shown previously that 
methylmercury blocks nerve-evoked release of acetylcholine, while 
11 
spontaneous quantal release of acetylcholine is first increased then 
decreased (35,36). These changes in spontaneous quantal release of 
transmitter are measured electrophysiologically as alterations of 
miniature endplate potential (MEPP) frequency (36). This is not due to 
impaired postjunctional sensitivity (37) or exhaustion of releasable 
transmitter stores (38). The present study investigated the idea that 
methylmercury might suppress nerve-evoked transmitter release by 
blocking the nerve terminal calcium channels which open during 
depolarization and permit calcium to enter which then triggers the 
release of transmitter. It was shown that methylmercury blocked the 
depolarization-induced calcium influx irreversibly and noncompetitively 
at the nerve terminals in both the central and peripheral nervous 
system. The block of calcium uptake by methylmercury was shown to 
differ from that of mercury in two ways. First, methylmercury reduces 
the total influx of calcium through a voltage-dependent pathway less 
effectively than inorganic mercury. Second, inorganic mercury more 
potently and efficaciously blocks the slow phase of calcium uptake, 
while methylmercury appears to block the fast phase of calcium uptake 
more effectively. However, the efficacy of methylmercury as a blocker 
is greater for the slow than fast components (35). 
This study was later supported by Levesque and Atchison in 1987 
(36) in which it was shown that methylmercury-induced stimulation of 
quantal release of acetylcholine at the neuromusclular junction was not 
blocked by agents which depolarize the mitochondrial membrane. However, 
the quantal release was blocked by an agent which blocks calcium influx 
specifically via the so-called "uniporter". Therefore, simple 
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inhibition of mitochondrial function does not prevent methylmercury from 
causing an increase in minature end-plate potential (MEPP) activity. It 
was suggested that methylmercury may interact with the mitochondria to 
induce the release of bound calcium stores into the nerve terminal 
cytoplasm. This increase in free ionized cytosolic calcium in turn is 
thought to promote the increased quantal discharge of acetylcholine 
observed as increased frequency of MEPP's (36). 
Neurotoxicity 
Although it has been well established that mercury and its 
derivatives are severe neurotoxins (1,3), the exact molecular basis of 
organic mercurial-induced neurotoxicity in humans and animals is largely 
unknown. Methylmercury, in contrast to the inorganic forms, passes with 
ease through physiologic barriers, such as the blood-brain barrier, 
blood-testes barrier, and placenta (39). Neuropathologic observations 
reveal the cortex of the cerebrum and cerebellum are selectively 
involved with focal necrosis of neurons, their lysis, and phagocytosis, 
and replacement with increased numbers of supporting glial cells. These 
changes are most prominent in the deeper fissures such as the visual 
cortex and insula (39). 
Omato et al. (40) demonstrated an inhibition of amino acid 
incorporation associated with possible defects in the cytosol fraction 
and microsomes isolated from brains of mercury-treated animals. 
However, they concluded that the primary site of organic mercurial 
action is not the protein synthetic per se. It was suggested that the 
ne·urotoxicity of mercury may be associated with other intracellular 
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processes coupled with the formation and/or regulation of the protein 
synthetic apparatus (40). 
Cheung and Verity (41) compared the perturbation of brain protein 
synthesis by methylmercury chloride in vivo and in vitro. These 
researchers found that stimulation of amino acid incorporation following 
in vivo administration of methylmercury was apparently associated with 
the ribosome fraction, while in vitro preincubation of the 
postmitochondrial supernatant with methylmercury produced stimulation 
associated with the pH 5 enzyme fraction. A model was proposed to 
explain the effects of methylmercury on brain protein synthesis which 
involves the existence of an inhibitor (or regulator) of protein 
synthesis that is highly sensitive to methylmercury. A more recent 
study by Cheung and Verity (42) identified the locus of mercurial 
inhibition of translation as a perturbation in the aminoacylation of 
tRNA which is not associated with defective initiation, elongation, or 
ribosomal function (42). 
The distribution and concentration of mercury in various areas of 
the brain have been studied by several investigators (43,44), but 
comparatively few microanatomical studies have been directed towards 
revealing the pathogenesis of the neurological lesions in mercury 
intoxication. Moller-Madsen and Danscher (45) examined the localization 
of inorganic mercury in the central nervous system of the rat. Adult 
Wistar rats of both sexes were given mercuric chloride in the drinking 
water at a dose level of 20 mg HgCl 2/liter distilled water ad libitum 
during an 8-month period. The animals were subsequently sacrificed and 
coronal sections of the brain and cervical spinal cord were examined 
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according to a histochemical technique based on a physical development 
process that makes mercury deposits visible {45). 
It was found that mercury deposits were not uniformly distributed in 
the brain and most mercury was located in the rhombenephalon. There was 
a clear tendency for those regions in the brain stem and cerebellum 
which are primarily associated with motor systems to contain the 
heaviest mercury accumulation. In fact, significantly more mercury was 
found within the motor nuclei than in sensory nuclei. Microscopic 
examination showed that within the regions of mercury deposition, large 
cells generally contained more mercury than smaller cells and that 
mercury was located intracellularly with neurons containing more mercury 
than glial cells {45). 
Research with methylmercury has provided a slightly different 
distribution pattern {46,47). Vandewater and associates {48) 
investigated the distribution, metabolism, and neurotoxicity of 
methylmercury using Swiss albino mice. An oral dose of [203Hg] 
methylmercury chloride {lOmg/kg) was given to male mice for a period of 
1 to 9 days. The methylmercury was evenly distributed among the 
posterior cerbral cortex, subcortex, brain stem, and cerebellum. The 
anterior cerebral cortex had a significantly higher methylmercury 
concentration than the rest of the brain.· A general trend of decreasing 
structural damage was observed with the cerebral cortex greater than the 
cerebellum greater than the subcortex greater than the brain stem. This 
uneven pattern of structural damage did not correlate with the brain 
distribution of methylmercury. It was suggested that various areas of 
the brain differ in their sensitivity to methylmercury since all areas 
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have the same methylmercury concentration and yet display different 
degrees of structural damage (48). 
Obviously, inorganic mercury and methylmercury are distributed 
differently in the brain and, at present, there is no satisfactory 
explanation for these differences. It has been suggested that inorganic 
mercury disrupts the barrier function of the plasma membrane first and 
then moves into the cell, inhibiting cellular functions. Methylmercury, 
on the other hand, penetrates the cells without any noticeable damage to 
the barrier. Therefore, the observed differences in the handling of 
mercuric chloride could be explained due to the differences between the 
plasma membranes of the motor and sensory neurons (48). 
Behavioral and neurophysiological changes are the earliest, and 
sometimes the only, indicators of chronic effects of exposure to 
neurotoxic agents (49,50). Clinical studies on patients exposed to 
mercury have shown a disturbance of visual perception as one of the most 
consistent signs of neurological impairment in humans. A concentric 
narrowing of the visual fields and reduced visual acuity is typically 
exhibited. The neurologic impairment underlying these visual anomalies 
appears to be lesions of the primary visual cortex. 
O'Kusky (51) examined the ultrastructural changes in neurons and 
synapses of the primary visual cortex in rats exposed to methylmercury 
in order to identify the morphologically distinct cell types undergoing 
degeneration at the onset of neurologic impairment. Subcutaneous 
injections of methylmercuric chloride in physiological saline were given 
to neonatal rats at a dose of 5 mg Hg/kg/day beginning on postnatal day 
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5. The injections were continued until the animal demonstrated a 
persistent weight loss for 48 hours (51). 
Clinical signs of neurologic impairment were relatively consistent 
among the nine methylmercury- treated animals with all animals 
exhibiting some degree of visual impairment. The vibrissa-placing and 
forelimb-placing responses appeared normal, but the visual-placing 
response was weak or absent. The methylmercury-treated animals, unlike 
the controls, failed to avoid a visual cliff, and when placed in a novel 
environment demonstrated difficulty in negotiating obstacles (51). 
In four of the methylmercury-treated animals convulsive activity 
was displayed and lesions of the primary visual cortex were more 
extensive than in the nonconvulsive animals. Examination by electron 
microscopy of the visual cortex in the nonconvulsive animals showed a 
selective degeneration of axon terminals forming symmetric synapses. It 
was suggested that a specific class of cortical neuron, the aspinous or 
sparsely-spinous ~tellate neuron, is particularly vulnerable to 
methylmercury toxicity. These neurons have been shown to form symmetric 
synapses in the visual cortex of the rat and contain glutamic acid 
decarboxylase which is the enzyme that synthesizes the neurotransmitter, 
Y-aminobutyric acid (GABA). The GABAergic inhibition of the neocortex 
is mediated by these intracortical neurons (51). 
The relatively selective impairment of GABAergic neurons in the 
visual cortex that occurs with methylmercury poisoning is consistent 
with the visual abnormalities that have been reported. For example, 
with impairment of the GABAergic neurons, a loss of orientation 
specificity in neurons of the visual cortex would explain the decreased 
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visual acuity. In addition, a loss of directional specificity may 
contribute to the concentric narrowing of the visual field as reported 
in some cases of methylmercury poisoning. The convulsive behavior 
exhibited by some of the animals exposed to methylmercury was suggested 
to reflect a seizure-induced pathology secondary to methylmercury 
impairment of GABAergic interneurons of the cerebral cortex. The exact 
cellular mechanism underlying the preferential degeneration of stellate 
neurons and symmetric synapses in methylmercury-treated animals is 
unclear. However, it has been proposed that an inhibition of 
mitochondrial respiration is involved (51). 
Slotkin and Bartolome (52) also examined alterations in nerve 
signal transmission with methylmercury toxicity. It was shown that 
postnatal exposure to methylmercury resulted in changes in 
neurotransmitter uptake and turnover in presynaptic terminals, as well 
as development of postsynaptic adrenergic receptor binding sites. These 
alterations resulted in aberrant signal transmission across the synapse. 
Therefore, the neurotoxicity observed with methylmercury may be due to 
degeneration of nerve synapses (52). 
Several recent studies conducted by Aschner in 1986 {53,54) 
examined changes in axonal transport in the rat optic system with 
methylmercury exposure. In one study, alterations in 
axonally-transported proteins in the retinal ganglion cells of rats were 
examined following exposure to methylmercury. Several groups 
of rats were given injections of methylmercury (4 mgHg/kg/day) for 
durations of 4-6 days and 12 days. Scintillation, histological, and SOS 
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polyacrylamide electrophoresis studies were employed to determine axonal 
transport (53). 
An increased rate and volume of transported protein-bound 
radioactivity was observed in the visual system of the mature rat 
treated with methylmercury. This is consistent with reports that 
synthesis and axonal transport increase when degenerative changes in the 
nerve create a demand for repair substances. Therefore, the increase in 
rate and volume of flow in the methylmercury-treated visual system of 
rats presumably reflects metabolic alterations designed to increase the 
supply of materials to the nerve terminal. It may represent a period of 
compensation during the early stages of methylmercury exposure (53). 
The composition of the transported polypeptides was analyzed by gel 
electrophoresis and selective changes were evident. These changes 
occurred in a small subset of proteins known as GAPs (growth-associated 
proteins). This indicated that the rat's visual system has the capacity 
to attempt regeneration; however, it is not clear whether this process 
can be maintained for long periods of time (53). 
It is well known that a latency period occurs between the time of 
administration of methylmercury and the onset of symptoms. It has not 
been determined whether increased protein synthesis and axonal transport 
are maintained throughout the symptomatic stage of methylmercury 
exposure. It needs to be determined if exhaustion of protein synthesis 
and axonal transport is correlated to the onset of functional deficits 
in these animals (53). 
Aschner's study helps explain the great specificity of 
methylmercury-induced injury in certain animal models, since some 
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systems appear to have regenerative capabilities (e.g. visual) .while 
other systems appear to fail in this aspect (e.g.-sciatic). It is 
important to understand these regenerative processes if future studies 
are to examine the effects of methylmercury on the visual system (53). 
Additional research has examined the effect of methylmercury on 
visual-evoked potentials (55) and spatial vision (56). It was shown 
that methylmercury decreased latencies of visual-evoked potentials and 
impaired spatial vision. Therefore, it would appear that methylmercury 
treatment has various effects on the visual system (55,56). 
One of the side effects of methylmercury poisoning is sensorineural 
hearing loss with subsequent impairment of speech discrimination. 
Morphological studies have shown damage to the cochlea and outer hair 
cells in the apex of the cochlea as well as the sensory epithelium and 
peripheral myelinated nerve fibres in the crista ampullaris with chronic 
inorganic mercury intoxication (57,58) .. However, the hearing loss due 
to methylmercury cannot be explained solely on the basis of receptor 
cell lesions (57). 
Wu and coworkers (57) examined cutaneous and auditory function in 
rats following methylmercury poisoning. Rats were given various doses 
of methylmercury chloride subcutaneously over a course of 5 days. Then, 
at varying times after the toxic exposure, up to one year, their sensory 
functioning was assessed using the behavioral method of reflex 
modification (57). 
The first signs of cutaneous deficits and hearing impairments were 
noted about 1 to 2 weeks after exposure to the higher dosages of 
methylmercury (40 and 50 mg/kg). These effects were revealed by 
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decrements in startle inhibition produced by both transient auditory 
stimuli and also by shocks to the tail which preceded the acoustic 
startle reflex {57). 
These deficits in cutaneous sensitivity and changes in reactivity 
are consistent with neurological damage produced in the periphery of the 
nervous system by exposure to methylmercury. However, auditory deficits 
are more difficult to explain. In the auditory processes of the 
superior temporal gyrus, central lesions have been observed in the 
primate brain. It has been suggested that these lesions may be at least 
partially responsible for the impairments in auditory perception noted 
in exposed humans. Since these impairments have been observed to be 
temporary in the rat, it was hypothesized that methylmercury produces 
demyelination in the auditory nerve which is equivalent to that seen in 
the dorsal roots of the spinal cord. Damage to the large fibers in the 
auditory nerve would thus impair the detection of rapid transients and 
other high frequency stimuli which is normally observed in humans 
exposed to methylmercury. However, some recovery may be seen following 
neural repair {57). 
Only a limited number of clinical methods exist for evaluating 
sensory, perceptual, and even motor systems in animals. However, it is 
known that the brain produces consistent and time-locked changes in 
electrical activity in response to auditory stimuli. Surface electrodes 
can be used to record these evoked potentials from auditory structures 
in the brainstem. These responses are referred to as auditory brainstem 
evoked responses {ABER) or auditory brainstem responses {ABR). Evoked 
response testing is a non-invasive technique which provides highly 
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objective information without subject cooperation. Thus, ABR 
evaluations are used by many investigators to detect neurologic, 
otologic or audiologic dysfunction in both human beings and animals 
(59,60). 
Auditory brainstem responses are averaged recordings of brain 
activity which result from an externally applied acoustic signal. By 
averaging these recordings, the background electrical activity can be 
extracted from the low voltage evoked components. The recordings 
consist of numerous waves with positive and negative peaks. Each wave 
represents composite neuronal activity of 1 or more brain structures. 
The activity of neural generators at progressively higher levels in the 
neuroaxis are generally represented by waves of successive auditory 
evoked responses with the early latency components arising almost 
totally within the brainstem. Thus, auditory brainstem responses 
reflect electrical events in the VIIIth cranial nerve and within the 
brainstem components of the auditory pathway (59). 
A number of studies have been conducted in an attempt to describe, 
from an anatomic perspective, the neural generators of the ABR waves. 
However, it has not been possible to identify a given wave with a single 
nucleus or tract due to the complexity of the sound pathway and perhaps 
the variability among animal species. Even so, a proposed scheme has 
been derived from a variety of experimental studies to relate each ABR 
wave as a reflection of a generator system. There is general agreement 
that Wave I of the ABR is produced by acoustic nerve activity. Wave II 
appears to be generated from the cochlear nucleus, however, there is 
less agreement concerning the origin of this wave. Research suggests 
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that the generator of wave III is the trapezoid body and/or superior 
olivary complex but attempts to differentiate discrete nuclei of the 
complex have been unsuccessful. Waves IV and V appear to originate from 
the area around and within the inferior colliculus. In certain animal 
species, waves VI and VII will be exhibited in ABR measurements but the 
generators for these waves remain unclear (59,60). 
Latency measurements of wave I can be used to examine the time from 
the inner ear or cochlea to the cochlear nerve. Therefore, this 
information may be used to indicate peripheral nerve damage which would 
effect the signal transmission to the CNS. Auditory threshold data can 
also be used to indicate this type of alteration. Wave amplitude data 
may be used to indicate the strength of the stimulus as the action 
potential reaches the different auditory centers of the brainstem. 
Interpeak latency (IPL) for waves I and Vis defined as central 
transmission time, and appears to be a good indication of impulse 
transmission through the brainstem, at least to the level of the 
inferior colliculus which is assumed to be the generator of wave V. 
Lesions involving the cochlear nerve and brainstem have been shown to 
result in a prolonged IPL. 
Thus, auditory brainstem response testing can be used to assess 
neurologic diseases, hearing impairment, as a measure of CNS maturation, 
and in monitoring the treatment of CNS disease. These diagnostic 
procedures have also been used in veterinary medicine to examine the 
effect of mercury intoxication on the auditory system of animals. 
A study was done by Wassick and Yonovitz (61) in which 
methylmercury ototoxicity was determined using auditory brainstem 
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responses. Two groups of mice were given subcutaneous injections of 
either 4 mg/kg for 17 consecutive days or 8 mg methylmercury/kg for 6 
days. Auditory brainstem responses were obtained as a result of 
pure-tone stimulation (4 to 78 kHz). To assure normal audibility and 
provide a baseline measure, pretreatment responses were obtained from 
each animal. Recordings were then taken weekly for three weeks after 
the initial injection. Latencies and physiologic thresholds were 
obtained from all 18 mice to assess methylmercury toxicity in order to 
elucidate which areas of the lower auditory pathway were affected (61). 
The 4 mg/kg group showed significant threshold deficits at all dose 
test periods. The decrement persisted up to the last test period which 
suggested that the deficits were permanent. The frequency having the 
greatest deficit was at 32 kHz, confirming a high-frequency loss (61). 
Significant threshold decrements with similar patterns to the lower 
dose group were also found in the 8 mg/kg group. However, the 16 kHz 
was the most affected frequency suggesting a loss in the most sensitive 
audibility range for mice. In addition, the overall deficit was not as 
great in this group. The reasons for these differences between dose 
groups were obscure, but may be related to differences between effects 
caused by acute and subchronic levels of methylmercury in the auditory 
system. Electron microscopic examination of the vestibular hair cells 
has shown a greater hair cell loss in chronically dosed animals than in 
the acute case and this is supporting evidence for a dose-dependent 
effect on the auditory pathway (61). 
Striking differences from pretreatment values were revealed in 
analysis of the latency test parameter. Loss in the high-frequency 
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range was suggested to be due to frequency-specific deficits to the 
lower auditory pathway. Absolute latencies also tended to be shortened 
for the majority of frequencies and time periods with methylmercury 
exposure. Thus, these authors proposed that this evidence indicated 
that methylmercury affected nerve processes which regulated nerve 
conduction velocity in the CNS. They suggested the possibility that 
methylmercury causes impairment of slow conduction. Damage of the small 
diameter fibers has been offered as one explanation for this 
hypersensitivity in nerve tissue. This would result in the majority of 
transmission being derived from fast conducting, large diameter fibers. 
If the small diameter fibers are more sensitive to methylmercury, this 
makes the small diameter nerve fibers in the brainstem a possible target 
for methylmercury (61). However, this is contradictory to the mechanism 
proposed by Wu et al. (57); therefore, further research is necessary to 
determine if it is the large or small diameter nerve fibers which are 
affected by methylmercury. 
In summary, there appears to be a difference in distribution 
patterns in the brain with exposure to inorganic mercury as compared to 
methylmercury (43,44,45,46,47,48). Various areas of the brain tend to 
be more susceptible to neurological damage depending of the type of 
mercury exposure (48). Synaptic degeneration has been shown in the rat 
visual cortex after administration of methylmercury. Also, 
methylmercury appears to preferentially attack certain neurons of the 
visual system (51,52). Changes in protein synthesis and axonal 
transport in the visual system have been determined, thus promoting the 
concept of regenerative processes occurring in the rat (53,54). 
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Research done using ABR methods to investigate the effect of 
methylmercury on auditory function has shown that this metal causes 
high-frequency auditory deficits in mice {61). Methylmercury may also 
alter the conduction velocity of auditory nerve fibers and, therefore, 
cause hypersensitivity in the brainstem, but it is unclear which fibers 
are most affected {61). In addition, methylmercury does appear to have 
a differential effect on cochlear and the lower auditory pathway 
depending on the dosage {61). It is clear that future research is 
needed to elucidate the mechanism of action by which methylmercury 
affects the auditory systems. 
Methvlation Process 
Although poisoning by inorganic mercurials has been known since 
ancient times, only recently has there been greater attention to the 
organic mercury compounds. Approximately 80% of our daily intake of 
mercury is methylmercury, with the average intake varying from 20 to 80 
µg/day or more in heavily contaminated foods {39). Methylmercury 
compounds pass easily through the blood-brain barrier and the placenta 
and are more likely to target the nervous system, testes, and the 
developing embryo/fetus (12,39). Additionally, the toxicity of 
short-chain alkylmercury compounds, such as methylmercury, is 
accentuated due to their persistence in mammals. 
A number of mechanisms have been proposed for metabolism of 
inorganic mercury in vivo. Early research has shown that rats injected 
with mercuric salts will excrete a small portion as volatile mercury, 
thus, suggesting that these animals are able to convert inorganic 
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mercury either by a methylation reaction or reduction to the metallic 
form (62). Additional research done by Ogata and associates (63,64) has 
demonstrated that elemental mercury can be oxidized to produce the 
mercurous ion, Hg2+
2
, and the mercuric ion, Hg++. The mercuric ion can 
then be reduced to metallic mercury due to the activity of the xanthine 
oxidase system. This can be reversed with catalase activity (64). 
Another metabolic fate of inorganic mercury compounds is the 
biomethylation of mercuric ions via methyl 812 which has been shown to 
occur in certain bacteria (65,66,67). 
Methylmercury is broken down slowly to inorganic mercury in the 
mammalian organism, but the site of demethylation has been difficult to 
determine (68). Suda and Takahashi (66) recently suggested that the 
spleen is an important site for the formation of inorganic mercury, and 
that macrophages participate in this biotransformation. It has been 
shown that the gut microflora also participate in the splitting of the 
carbon-mercury bond of methylmercury to produce inorganic mercury 
(66,67). 
Therefore, it is important to examine the process by which 
inorganic mercury is converted to the potentially more toxic form of 
methylmercury. It has been established that bacteria not only in the 
soil and lakes, but also the intestinal tract can convert metallic and 
inorganic mercury forms to methylmercury (39,69,70,71,72). Pan-Hou and 
Imura (73) have shown that methylation of mercury which is mediated by 
methycobalamin may play an important role in the detoxication of the 
mercury by certain vitamin B12-requiring strains of microorganisms. 
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On the basis of oxidation-reduction chemistry, the conditions for 
biomethylation can be formulated. Methylating agents which are 
available for methyl transfer in biological systems are known to involve 
three major coenzymes: 1) S-adenosylmethionine; 2) N5-methyl-
tetrahydrofolate derivatives; and 3) vitamin 812 derivatives. Research 
has indicated that vitamin 812 derivatives are the methylating agents 
for inorganic mercury salts since they are capable of transferring 
carbanion methyl groups (CH3-). S-adenosylmethionine can donate 
carbonium methyl groups (CH3+), while N5-methyltetrahydrofolate can 
yield free radical methyl groups (CH3.). Since vitamin 812 is capable of 
transferring methyl groups as free radicals (CH3.), carbonium ions, or 
carbanions (Figure 1), theoretically there are three mechanisms which 
may be involved in the methylation of a number of metals, such as gold, 
tin, and platinum (8). 
To date, two general mechanisms have been found for the methylation 
of a metal or metalloid by methylcobalamin: reactions in which the 
metal or metalloid acts as an electrophile (type I) and reactions in 
which the metal or metalloid acts to abstract a methyl radical (type 
II). The methylation of mercury is an example of type I which involves 
heterolytic cleavage of- the Co-C bond of methylcobalamin with the 
transfer of a carbanion methyl group to the more oxidized state of the 
element, i.e. a carbanion methyl group is transferred to mercury to form 
methylmercury and a water molecule coordinates in the fifth ligand site 
of the cobalamin to give aquocobalamin [Co(III)] as a final product 
(Figure 2) (8). 
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Figure 1. Examples of methylation reactions involving 
vitamin B12 (8). 
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Figure 2. Mechanism for vitamin B12-dependent methyl transfer to mercuric ion (type IJ (8). 
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Hg(II) 
An example of a type II reaction is the methylation of thiols by 
methylcobalamin and involves reductive hololytic cleavage of the Co-C 
bond of methylcobalamin with the transfer of CH3• and the production of 
Co(II) cobalamin. The CH3• couples with the attacking metal or 
metalloid which results in a one-electron oxidation of the attacking 
element (8). 
There is a metabolic interrelationship between folate, B12 , and 
methionine, but several important points remain unclear (9,74). The 
reaction which involves the enzyme, N5-methyltetrahydrofolate 
methyltransferase, is an example of this interrelationship. As shown in 
Figure 3, this enzyme transfers a free radical methyl group from 
N5-methyl tetrahydrofolate to vitamin B12 (Co+2). The B12 can then 
donate the free radical methyl group to homocysteine to form methionine 
and regenerate the Co+2 form of B12 • Methionine can be used to form 
S-adenosyl-methionine with the hydrolysis of ATP. Occasionally, for 
reasons not fully understood, the Co+2 form of B12 becomes oxidized to 
Co+3. When this occurs, riboflavin (FADH2 ) can be used to reduce the 
B12 to the Co+l form. S-adenosylmethionine will donate a carbonium 
(CH3 +) methyl group to regenerate the Co+2 form of B12 • Thus, the cycle 
can begin again. 
Use of Meqavitamins 
Since vitamin B12 , and possibly folate, appear to be involved in 
the methylation process of inorganic mercury, it is possible that 
individuals consuming megadoses of these vitamins may exhibit elevated 
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levels of methylmercury. Thus, it becomes important to examine the use 
of megavitamins in our society. 
Vitamin advocates have in recent years argued that supplements, 
often in amounts ten or more times higher than recommended, will guard 
against a profusion of physical and psychological ills. Consumption is 
often encouraged by the philosphy that if a little is good, a lot is 
better (75). Consequently, the supplement business has blossomed intoa 
multibillion dollar industry due to the large-scale consumption of these 
products. It has been estimated that 40% to 50% of the adult 
population, both active and sedentary, rely on self-prescribed vitamin 
supplements (75,76,77). Athletes, coaches, and athletic trainers appear 
to be choice targets for the supplement sales force (76). Nutrition 
articles and advertisements in popular sports magazines have convinced 
some naive consumers that large doses of nutritional supplements are 
required for the active individual (76). 
The vitamin B complex is one popular supplement that athletes 
consume. It has long been assumed that the water-soluble vitamins are 
nontoxic since excesses are excreted in the urine (76,78). These 8 
vitamins, thiamin, riboflavin, niacin, pyridoxine, folacin, panthothenic 
acid, biotin and 812 , have been promoted to enhance athletic 
performance, but research has not supported.this claim (76). 
Additionally, megadoses of the B vitamins have been reported to cause a 
number of side effects (78). 
Probably the two most popular vitamin supplements are vitamin C and 
E (76,78,79). The sale of ascorbic acid supplements has skyrocketed due 
to Linus Pauling's claim that massive doses of vitamin C can cure colds. 
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Although the RDA for ascorbic acid is 60 mg a day, megadose advocates 
say we need as much as 10,000 mg (79). Like the B complex, vitamin C is 
soluble in water and excesses are excreted. No studies support the 
efficacy of vitamin C supplements as an ergogenic aid, and undesirable 
side effects have been demonstrated with large doses (76,80,81). 
Potential Relationship of Megavitamins and Mercury Metabolism 
Thus, as the research indicates, mercury presents human health 
hazards due to contaminated fishing waters and dental amalgams. Mercury 
apparently can exhibit toxic effects at various sites throughout the 
mammalian system and of significant importance is the possible 
neurotoxicological effects as a result of methylation processes which 
occur in vivo. This biomethylation of inorganic mercury via vitamin B12 
suggests that higher levels of this vitamin may increase the amount of 
methylmercury found in the body. With the increased consumption of 
vitamin supplements in the United States, it is conceivable that mercury 
toxicity could rise significantly. Therefore, this project investigated 
the effect of megadoses of vitamins on the metabolism of mercury in 
various mammalian tissues. In order to examine possible neurological 
effects, auditory brainstem responses (ABR) were measured. 
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CHAPTER III 
EXPERIMENTAL PROCEDURE 
General Outline of Research 
In order to study the effect of dietary intake on the in vivo 
methylation processes of inorganic mercury as well as the neurotoxic 
effect of methylmercury, three phases of investigation were conducted. 
Initially, the diets of guinea pigs were altered to include high levels 
of vitamin 812 , folate, and/or vitamin C. The effect of megavitamin 
ingestion on the methylation of mercury in various tissues of these 
animals was then examined. Next, the effect of dietary sulfur amino 
acid content on mercury metabolism was studied in rats by diet 
supplementation with methionine or cysteine. Finally, auditory 
brainstem evoked responses were used to study the neurotoxic effects of 
mercury metabolism and how these effects could be possibly altered by 
various dietary manipulations. 
Preparative and Analytical Instrumentation 
All reagents were analytical grade and specially selected for their 
low mercury content. Glassware was cleaned with nitric acid (4M) and 
rinsed with demineralized water. All solutions were prepared using 
demineralized water only. 
Tissue homogenization was done on ice using a Brinkmann polytron 
homogenizer (Brinkmann Instruments, Inc., Westbury, N.Y.). All mercury 
assays were performed using 300 ml Wheaton Biological Oxygen Demand 
(8.0.D.) bottles. A controlled-temperature, water bath shaker 
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(Precision Scientific Company, Chicago, IL.) was employed for tissue 
digestion. 
Subsequent mercury determinations were carried out by cold-vapor 
atomic absorption spectrometry. Absorption was measured with a 
Perkin-Elmer Model 3030 atomic absorption spectrophotometer equipped 
with a mercury, hollow cathode lamp. A cold-vapor apparatus was 
laboratory assembled according to directions provided by a Perkin-Elmer 
representative (personal communication) with an absorption cell (100 mm 
X 20 mm i.d.) used for the AAS measurements. The gas was first passed 
through an absorption cell (50 mm X 20 mm) containing potassium 
persulfate (Baker Chemical Company, Phillipsburg, N.J., Analytical 
Grade) which dried the material. After each measurement, the mercury 
was adsorbed in a carbon absorption tube (65 mm X 35 mm i.d.) which was 
connected to the apparatus with a bypass arrangement. The system was 
closed by means of a peristalic pump. 
Animal Model 
A pilot study was initially conducted to determine whether rats or 
guinea pigs would be best suited for the megavitamin portion of this 
study. It was determined that folacin and vitamin B12 play a more 
active role in the guinea pig than in the rat. This is possibly due to 
the fact that the guinea pig requires these vitamins for regeneration of 
methionine while the rat has a more active choline oxidase system (82). 
Consequently, the guinea pig accumulates more folacin and vitamin B12 
than the rat with a dietary excess (83). A total of 55 male guinea pigs 
weighing approximately 250 grams were purchased from Hilltop Laboratory 
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Animals, Inc. (Scottdale, PA) and maintained on a 12-hour light-dark 
cycle in a controlled temperature environment. 
Vitamin Preparation 
Vitamin 812 and folic acid were purchased from ICN 8iomedicals, 
Inc., Cleveland, OH, while L-ascorbic acid was obtained from Sigma 
Chemical Company, St. Louis, MO. Each vitamin was weighed and 
subsequently triturated with sucrose to a total weight of 500 g, which 
gave a final concentration of 4 mg folic acid, 50 µg 812 , and 1.8 g 
ascorbic acid per 4 g of triturate. This was then added to ground 
guinea pig chow at a concentration of 4 g/100 kg. The various vitamin 
combination mixtures and individual vitamin supplements were derived by 
adjusting the amount of sucrose so that vitamin concentrations remained 
constant. The control diet was prepared by adding sucrose at a 
concentration of 4 g/100 kg ground chow. 
Dietary Regime 
Vitamin treatment. Eight groups of five guinea pigs each were fed 
Purina Guinea Pig Chow 5025 and megadoses of vitamin B12 , folate, and/or 
vitamin C. The control diet consisted of animals fed ad libitum chow 
which contained all vitamins at levels required for normal guinea pig 
nutriture. One group of animals was fed a diet supplemented with 
megadoses of vitamin 812 , folate, and vitamin C. This group was 
referred to as the all vitamin treatment animals. Three groups of 
animals were provided diets which included megadoses of either 812 and 
folate, 812 and vitamin C, or folate and vitamin C. These groups served 
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as the combination vitamin treated animals and were referred to 
according to their respective vitamin blends. Finally, three groups of 
guinea pigs were given diets supplemented with the individual vitamins. 
These groups were called by the respective vitamin treatment, i.e. B12 
only, folate only, vitamin Conly. All diets were fed ad libitum for a 
total of eight weeks. Distilled water was freely available to all 
animals. Two groups of guinea pigs were weighed weekly to assure proper 
weight gain and feed consumption with vitamin treatment. Otherwise, all 
animals were housed in groups in polycarbonate cages with stainless 
steel wire lids and a raised wire floor with hardwood chip bedding. 
Methionine and cysteine supplementation. Three groups of five 
each weaning-age (45-60 g bw.), male Sprague-Dawley rats (Taconic Farms, 
Germantown, N.Y.) were fed their respective diets for a 17 day dietary 
period. Animals were fed ad libitum one of three different 15% 
casein-based diets: 1) unsupplemented; 2) ·supplemented with 0.625% 
methionine; or 3) supplemented with 0.505% cysteine as shown in Table I 
(84). Distilled water was readily available and the animals were housed 
individually in galvanized wire-bottom cages. 
Mercury Treatment 
At the end of the dietary period, each animal was given 0.6 mg 
HgC1 2/kg body weight as a subcutaneous injection in isotonic saline 
every other day for nine doses (85). Animals were observed throughout 
this treatment period for overt signs of mercury toxicity. Twenty-four 
hours after the last injection, the animals were sacrificed and their 
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Table 1. Composition of Methionine or Cysteine Supplemented Diets 
Dietary 
Constituent Unsupplemented 
g/lOOg 
Casein 15 
Sucrose 30 
Cornstarch 30 
Vegetable Oill 2 
Vegetable Short~ning2 6 
Vitamin Mixtur~ 2 
Basal Salt Mix 1.34 
CaC03 1.32 
CaS04-2H205 0.04 
Methionine 
Cysteine 
Non-nutritive bulk6 12.3 
lwesson Oil -- Hunt-Wesson Foods, Inc. 
2crisco -- Proctor and Gamble. 
Methionine Cvsteine 
g/lOOg g/lOOg 
15 15 
30 30 
30 30 
2 2 
6 6 
2 2 
1.34 1.34 
1.32 1.32 
0.04 0.04 
0.625 
0.505 
11. 7 11.8 
3Nutrition Biochemicals Corporation, Cleveland, Ohio. Vitamix 
diet fortification mixture was formulated to supply the following 
amounts of vitamins (g/kg vitamin premix): thiamin hydrochloride, 1.0; 
riboflavin, 1.0; niacin, 4.5; p-aminobenzoic acid, 5.0; calcium 
pantothenate, 3.0; pyridoxine hydrochloride, 1.0; ascorbic acid, 45.0; 
inositol, 5.0; choline chloride, 75.0; menadione, 2.25; biotin, 0.020; 
folic acid, 0.090; vitamin B12, 0.00135; a-tocopherol, 22.0; vitamin A, 
1.8; vitamin D, .125; and sufficient glucose to make 1 kg. 
4Formulated to contain the following amounts of minerals (g/500g 
salt mixture): magnesium carbonate, 33.7; sodium chloride, 77.4; 
potassium chloride, 125.4; potassium monobasic phosphate, 237.8; ferric 
phosphate, 23; potassium iodide, 0.090; sodium fluoride, 0.01; 
manganese chloride, 0.45; aluminum potassium sulfate, 0.019; cupric 
acetate, 0.810 and zinc carbonate, 4.8. 
5caS04-2H20 provided 0.02% S04=. 
6Alphacel -- ICN Biochemical. 
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liver, spleen, heart, kidneys, lungs, and brain were removed and frozen 
at -80°C for subsequent mercury determinations. Muscle tissue was also 
removed from the thigh of the hind leg. In addition, hair samples were 
taken from the guinea pigs and blood samples were taken from several 
treatment groups. However, blood, muscle, and hair tissues were not 
analyzed in rats. 
Animal Sacrifice and Tissue Preparation 
Guinea pigs were anesthetized with a 10 ml interperitoneal 
injection of 1% Brevital Sodium (Eli Lilly and Co., Indianapolis, IN) 
and decapitated with shears. Blood was immediately collected in test 
tubes and stoppered. Rats were stunned by a blow to the back of the 
head and decapitated with shears. Selected tissues were rapidly excised 
from all animals, placed in storage containers on ice, and subsequently 
stored at -80°C. Hair samples were also taken from the back of the 
guinea pigs' necks and stored. 
Upon thawing, a 25% (w/v) homogenate was prepared for each tissue, 
except blood and hair, using 1.5 M potassium hydroxide (w/v). Mercury 
has been shown to be stable in alkaline media over extended periods and 
alkali is more effective than acid in the hydrolyzation of protein (86). 
The majority of methylmercury (more than 90%) and approximately 50% 
of metallic mercury in the blood has been found within the erythrocytes 
(87). Additionally, it has been reported that determination of mercury 
in blood samples can be difficult due to low concentrations (88). 
Therefore, blood samples were thawed and homogenized without dilution 
until a uniform solution was obtained. This was the form used for 
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subsequent mercury analysis and reflected all blood sample 
constituents. 
Hair has been shown to accumulate and retain mercury over the life 
of the hair fiber. Thus, it is an excellent retrospective indicator of 
mercury in cases of acute poisoning as well as prolonged uptake of low 
concentrations of mercury compounds (14,89). In the present study, a 
weighed sample of 0.25 g hair was used for mercury analysis. 
Selective Determination of Inorganic Mercury and Methylmercury by 
Cold-Vapor Atomic Absorption 
One of the major problems in mercury analysis is the need to 
destroy the organic material and release the mercury from the sample 
(4,86). A number of methods exist for the destruction of organic 
materials (4,86,90,91). However, techniques requiring the digestion of 
samples do not enable inorganic mercury and methylmercury to be 
distinquished (86,90-97). Consequently, many methods have been proposed 
which involve the extraction of methylmercury using benzene and/or 
toluene (24,98-101). However, experimentation in this lab resulted in 
the conclusion that these methods could not be used by atomic 
absorption, as benzene and toluene gave falsely high readings. 
Experiments in which labelled mercury compounds were used have shown 
that inorganic mercury can be selectively determined in the presence of 
organomercurials by its selective reduction with tin (II) chloride 
(102). Magos et al. (88,103) discovered that the rate of methylmercury 
reduction and other organomercurials by tin (II) chloride can be made 
identical to that of inorganic mercury. This can be done if the amount 
of tin (II) chloride is above a certain level and a cadmium salt is 
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added to the reaction mixture. Thus, a method was developed so that 
inorganic mercury can be released first, followed by the release of 
methylmercury from the same sample (88,103). 
The method used in this research was adapted from several sources 
(14,104-108) and allows for selective reduction of inorganic mercury and 
methylmercury using the same sample. These two measurements were then 
added together to determine total mercury concentration. 
Mercury standard solutions. A mercury (-II) stock solution was 
prepared by dissolving 0.6767 g HgC1 2 (Fisher Scientific Company, 
Memphis, TN., Analytical Grade) in 0.05 M sulfuric acid and diluting to 
100 ml volume with the same acid solution. This yielded a concentration 
of 1.000 mg Hg/ml. From this solution, a working standard was prepared 
by diluting with acid solution to provide a total concentration of 0.4 
µg Hg/ml. 
The methylmercury stock solution (500 µg/L) was prepared by 
dissolving 62.58 mg CH3HgCl (Pfaltz & Bauer, Inc., Waterbury, CT) in 100 
ml of 95% ethanol. The working standard was prepared by diluting with 
demineralized water and yielded a final concentration of 0.5 µg 
CH3Hg/ml. 
Reagents. Solutions of 1% (w/v) L-cysteine, 1% sodium chloride, 
and 45% sodium hydroxide were prepared by dissolving these compounds in 
appropriate amounts of demineralized water. An 8 M sulfuric acid 
solution was also prepared using demineralized water. These were all 
analytical grade reagents which had been tested for mercury content by 
the manufacturer. 
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A 10% (w/v) tin (II) chloride solution was prepared by dissolving 
SnCl 2 • 2H20 (Baker Chemical Company, Phillipsburg, N.J., Hg content< 
0.5 ppm) in dilute HCl solution (100 ml concentrated HCl/L). This was 
prepared fresh daily. 
The tin (II) chloride - cadmium (II) chloride solution was prepared 
by dissolving 25 g of SnC1 2 • 2H20 and 5 g CdC1 2 • 2.5H20 (American 
Scientific Company, Stone Mt., GA) in 50 ml of dilute HCl. The solution 
was then heated and mixed until it was clear. This solution was also 
prepared fresh daily. 
Procedure. Representative samples of each tissue homogenate were 
pipetted to 8.0.D. bottles: 5 ml of liver and muscle; 2.5 ml of brain, 
lungs, and heart plus 2.5 ml of 1.5 M KOH; 1.0 ml of kidney and spleen 
plus 4.0 ml of 1.5 M KOH; 1 ml of blood plus 5 ml of 1.5 M KOH; and 0.25 
g weighed hair sample plus 5.0 ml of 1.5 M KOH. Then, 1 ml of 1% 
cysteine and 1.24 ml of 12 N sodium hydroxide were added to each 
reaction vessel. At all times, a total of 22.4 meq of hydrogen 
ions was maintained in each sample solution. The samples were digested 
in a water-bath at 85°C for five minutes. After digestion, the samples 
were immediately placed in an ice bath and 12.76 ml of 1% sodium 
chloride were added to each bottle. Total reaction volume was 20 ml and 
all samples were maintained on ice until AAS was performed. 
Approximately 30 minutes before the start of a run, the atomic 
absorption spectrophotometer was switched on and the absorption reading 
verified at 253.7 nm. At the beginning of each run, inorganic mercury 
standards were run by adding 1 ml of 10% stannous chloride solution and 
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absorption values read. Also, absorption was determined for the 
methylmercury standard. 
Each 8.0.D. bottle containing the digested sample was placed in a 
ice water bath under the aerator tube assembly. The following were 
added in sequence; 1-2 drops Antifoam A Emulsion (Sigma Chemical 
Company, St. Louis, MO), 10 ml of 8 M sulfuric acid, 1 ml of 10% tin 
(II) chloride solution, 20 ml of 45% sodium hydroxide, and 50 ml of 
demineralized water. The aerator was immediately attached, the pump 
turned on, and the air flow was continued through the reaction vessel 
for exactly one minute. At this time the absorption peak for inorganic 
mercury was read. The aerator tube was immediately removed from the 
sample and the air flow switched to remove the mercury through the 
activated charcoal chamber. The pump was allowed to run for a maximum 
of one minute or until absorption was zeroed, at which time the air flow 
was stopped. 
Exactly two minutes after the first reduction process was begun, 10 
ml of 8 M sulfuric acid, 2 ml of tin (II) chloride - cadmium chloride 
reagent, and 20 ml of 45% sodium hydroxide were added sequentially to 
the sample. The aerator tube was attached immediately and the pump was 
switched on. The reaction was allowed to occur until a maximum 
absorption peak for methylmercury was obtained and recorded. At the end 
of the run, the air flow was again diverted through the charcoal 
absorption tube to remove all mercury. 
The concentrations of inorganic mercury and methylmercury were 
subsequently calculated using the standard solution concentrations and 
absorption values. All samples were run in duplicate and extreme 
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variations (over 5%) in measurements resulted in repeated assay of the 
sample. 
Auditory Brainstem Response (ABR) Testing 
Preyor's reflex was performed on all animals midway through mercury 
treatment and immediately before ABR testing was conducted. This 
consisted of visual observation of ear twitching in response to a loud 
noise. 
All ABR recordings were obtained in a quiet room. Animals were 
anesthetized with isoflurane. Recording electrodes were placed 
subcutaneously at the vertex and over the mastoid of the right ear and a 
ground electrode was inserted into the nap of the neck. Active 
electrode impedence was controlled below 10 kn and normally was within 
1 kn of a reference electrode. The right ear was tested with pure tones 
while the left ear received white noise which was 30 dB SPL (sound 
pressure level) less than the testing signal. Potentials were evoked 
using pure tones of alternating polarity at a rate of 11.4/sec. The 
potential difference between the vertex and the mastoid electrode 
ipsilateral to the stimulated ear was amplified and band-passed at 
150-3000 Hz. Responses (10 msec) to 256 stimuli were averaged to 
produce each ABR and a repetition of each stimulus paradigm condition 
was made to assess reproducibility. A total of four stimulus 
frequencies (8k, 6k, 4k, and 2k) were used beginning at an intensity of 
105 SPL and decreasing in 10 dB steps until close to threshold and then, 
5 dB steps to threshold. Following each experiment, the animals were 
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given an otoscopic examination to assure that the ear canal was free of 
cerumen. 
After all tests were completed, hard copies of each recording were 
made. Four to 5 peaks of the averaged signal were identified and 
labeled with Roman numerals. In most cases, only one wave occurred in 
the III and IV latency range. Therefore, no value was recorded for wave 
IV and the single wave (III and IV complex) was labeled as wave III. 
Wave latencies were measured for waves I, II, and V with latency defined 
as the time from stimulus onset to the positive peak of each wave. 
These measurements were recorded to the nearest 0.01 msec. The 
amplitude of each wave was determined by measuring from its peak 
positivity to the following negative trough. These measurements were 
recorded to the nearest 0.01 µV. Interpeak latency (IPL) was derived by 
subtracting the wave I latency from the wave V latency. In addition, 
thresholds were determined by the appearance of peak I as an indicator. 
Statistical Analysis 
All data were evaluated by Analysis of Variance (ANOVA) performed 
with SAS (SAS Program, University of Tennessee) using the General Linear 
Model (GLM) procedures. Differences between groups for each tissue were 
determined by Duncan's multiple-range test (109). 
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CHAPTER IV 
RESULTS 
This research project consisted of three separate investigations. 
First, several groups of guinea pigs were fed either a control diet or a 
diet which included megadoses of vitamin 812 , folate, and/or vitamin C 
in various combinations. After eight weeks on the diet regime, these 
animals were given an injection of mercuric chloride every other day for 
a total of nine injections, sacrificed, and tissues removed. Each 
tissue was then analyzed for inorganic and methyl mercury. Total 
mercury and the percent inorganic and methyl mercury were subsequently 
determined. Weight/growth data were obtained for one group of guinea 
pigs fed either a control or 812/folate diet. This information is 
charted on Figure 4 and the measurements are shown in Appendix 1. These 
data indicated that both groups had consistent weight gain, therefore; 
difference in growth was not a factor in the mercury data analysis. 
Also after mercury injections were begun, a slight weight loss was 
observed in both groups which is a phenomenon reported by a number of 
researchers (32,51,54,57). 
Since methionine is also a potential methyl donor in mammals, a 
second aspect of this research was to investigate the effect of 
methionine or cysteine on mercury metabolism in rats. These animals 
were fed either a control diet, or methionine or cysteine supplemented 
diet for seventeen days, then given mercury injections every other day 
for a total of nine injections. After sacrifice, the tissues from these 
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animals were also analyzed for inorganic and methyl mercury with 
subsequent determination of total and percent mercury. 
Finally, several groups of guinea _pigs treated with megavitamins 
and mercury were tested for auditory brainstem responses (ABR). 
Following ABR evaluation the animals were sacrificed and tissue mercury 
analysis performed. The ABR data were used to examine the neurotoxicity 
of mercury. 
The results reported here are divided into guinea pig data, rat 
cysteine/methionine data, and ABR analysis. Additionally, the guinea 
pig data are further divided into controls versus all vitamin dietary 
regime, controls compared to various vitamin combinations, and controls 
versus animals treated with megadoses of the individual vitamins. 
Controls vs All Vitamins 
A total of eight tissues were analyzed for inorganic and 
methylmercury. These values were added together to derive total mercury 
levels. Percent values were also calculated. The results are shown on 
Table 2. There were several trends observed between the two groups. 
Inorganic mercury was higher in the heart (1.29 µg vs .72 µg) and 
lungs (.82 µg vs .74 µg) in the vitamin treated group compared to 
controls. However, inorganic mercury was lower in the liver (.52 µg vs 
.78 µg), muscle (.10 µg vs .21 µg), brain (.19 µg vs .30 µg), spleen 
(.52 µg vs .89 µg), kidney (16.96 µg vs 19.17 µg) and hair (.73 µg vs 
.80 µg) in the vitamin group compared to controls. 
Methylmercury tended to follow the same trends as the inorganic 
form. It was lower in the vitamin group than controls in the liver 
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Table 2. Mercury Levels in Various Tissues of Guinea Pigs with the All-Vitamin Dietary Regime 
µg Hg/g wet tissue 
Treatment Inorganic Hg Methyl Hg Total Hg % Inorganic % Methyl 
Liver 
Controls (n=l8) .78 ± .28 .37 ± .20 1.15 ± . 46 69 31 
Vitamins (n=8) .52 ± .12 .25 ± .03 .77 ± .14 67 33 
Muscle 
Controls .21 ± .27 .18 ± .14 .39 ± .38 51 49 
Vitamins .10 ± .02 .13 ± .09 . 23 ± .10 47 53 
Brain 
U1 Controls .30 ± .17 .24 ± .15 .54 ± .31 56 44 
0 Vitamins .19 ± . 06 .18 ± .07 .37 ± .11 51 49 
Heart 
Controls .72 ± .61 .35 ± .19 1.07 ± .76 63 37 
Vitamins 1.29 ± .91 .60 ± .33 1.90 ± 1.24 66 34 
Lungs 
Controls (n=l3) .74 ± .18 .40 ± .07 1.14 ± .22 65 35 
Vitamins .82 ± .16 .41 ± .07 1.23 ± .21 67 33 
Spleen 
Controls .89 ± .51 .59 ± .20 1.48 ± .69 58 42 
Vitamins .52 ± .10 .41 ± .10 .93 ± .18 56 44 
Kidney 
Controls 19.17 ± 2.49 14.72 ± 2.11 33.89 ± 4.49 57 43 
Vitamins 16.96 ± .75 13. 46 ± .80 30. 42 ± 1. 44 56 44 
(J'1 
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Table 2. (Continued) 
u g Hg/g wet tissue 
Treatment Inorganic Hg Methyl Hg Total Hg % Inorganic % Methyl 
Hair 
Controls (n=13) .80 ± .26 .65 ± .23 1.44 ± .47 55 45 
Vitamins .73 ± .33 .70 ± .25 I. 43 ± . 48 51 49 
Values represent the average± S.D. The data for the all-vitamin treated group was not 
statistically different from controls. 
(.25 µg vs .37 µg), muscle (.13 µg vs .18 µg), brain (.18 µg vs .24 µg), 
spleen (.41 µg vs .59 µg) and kidney (13.46 µg vs 14.72 µg), while it 
was higher in the heart (.60 µg vs .35 µg) and the lungs (.41 µg vs .40 
µg). The only exception was found in hair tissue, which contained a 
higher methylmercury content in the vitamin groups (.70 µg) compared to 
controls (.65 µg). 
The vitamin group exhibited lower total mercury concentrations in 
the liver (.77 µg vs 1.15 µg), muscle (.23 µg vs .39 µg), brain (.37 µg 
vs .54 µg), spleen (.93 µg vs 1.48 µg), kidney (30.42 µg vs 33.89 µg), 
and hair (1.43 µg vs 1.44 µg) compared to controls. Total mercury 
tended to be higher in the vitamin group than controls in the heart 
(1.90 µg vs 1.07 µg) and the lungs (1.23 µg vs 1.14 µg). 
Interestingly, tissues from the vitamin group that had lower 
mercury concentrations had a higher percent of mercury as methylmercury. 
For example, the percent methylmercury in the liver (33% vs 31%), muscle 
(53% vs 49%), brain (49% vs 44%), spleen (44% vs 42%), kidney (44% vs 
43%), and hair (49% vs 45%) was higher in the vitamin treated group 
compared to controls. Both the heart and lungs had lower percent 
methylmercury for vitamins versus controls (34% vs 37%, and 33% vs 35%, 
respectively). 
As noted, there were a number of trends exhibited between the 
vitamin treated group and control animals. However, these differences 
were not statistically significant in any of the tissues analyzed. 
52 
Controls vs Vitamin Combinations 
The results from five tissues are shown in Table 3. In the liver 
there was no statistical difference found between controls, 812/vitamin 
C and folate/vitamin C for inorganic, methyl, and total mercury, as well 
as percent inorganic and methylmercury. The 812/folate group was 
significantly higher than controls for inorganic mercury (1.05 µg vs .78 
µg), methylmercury (.67 µg vs 37 µg) and total mercury (1.72 µg vs 1.15 
µg). Also the percent methylmercury was higher (p < 0.05) in the 
812/folate group (40%) compared to controls (31%). In addition, the 
812/folate group had values which were significantly greater than the 
812/vitamin C group for inorganic, methyl, total, percent inorganic, and 
percent.methylmercury, but had statistically different values from the 
folate/vitamin C group for only methylmercury concentration. 
There were no differences between the control, 812/folate, and 
812/vitamin C groups for the various mercury concentrations and percent 
measurements in muscle. The folate/vitamin C group was statistically 
different from the controls and the other combination groups for 
inorganic, methyl and total mercury concentrations, but was not 
different in percent inorganic or percent methylmercury for this tissue. 
Interestingly, the two 812 groups (812/folate and 812/vitamin C) showed a 
higher percent methylmercury (61% and 57%, respectively) compared to the 
control and folate/vitamin C groups (49% and 50% respectively). 
However, this difference was not statistically significant. 
In the brain, no differences were observed between controls and the 
vitamin combinations for inorganic, methyl or total mercury. The 
812/vitamin C group had a higher (p < 0.05) percent of mercury as 
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Table 3. Mercury Levels in Various Tissues of Guinea Pigs with the Vitamin Combination Dietary 
Regime 
ug Hg/g wet tissue 
Treatment ln~rganic Hg Methyl Hg Total Hg % Inorganic % Methyl 
Liver 
.78 ± .28a,b 1.15 ± .46a,b Controls .37 ± .20~ 69a 316 
812/Folate 1.05 ± .25a .67 ± .09 I. 72 ± .33~ 6ob,c 40 ,c 
B1fVitamin C .61 ± .o9b .27 ± .o4a .88 ± .13 69a 31a 
Fo ate/Vitamin C . 78 ± .10a, b .38 ± .01a 1.15 ± .10a,b 67a,b 33a,b 
Muscle 
Controls .21 ± .21a .18 ± .14a .39 ± .38a 51a,b,c 49a,b,c 
812/Folate .12 ± . 03a .19 ± .o4a .31 ± .o4a 39b 61b 
B1fVitamin C .27 ± .29ab .31 ± .19~ .58 ± _45a 43a,b 57b,c 
Fo ate/Vitamin C 1.33 ± 1.60 .83 ± .83 2 .16 ± 2. 40b 5oa,b,c 5oa,b,c 
Brain 
Controls .30 ± .I7a . 24 ± .15a .54 ± .31a 56a,b 44a,b 
812/Folate .16 ± .02a .15 ± . 03a .31 ± .o4a 51b 49a 
B1fVitamin C .20 ± .o8a .29 ± .14a .49 ± .22a 41c 59c 
Fo ate/Vitamin C .25 ± .o9a .18 ± .oga .43 ± .14a 58a,b 42a,b 
Heart 
Controls .72 ± .61a,b .35 ± .19~,b 1.07 ± .76a,b 63a 37a 
812/Folate .26 ± .o3b .33 ± .19b .59 ± .2ob 48b 52b 
B1fVitamin C .44 ± .31b .23 ± .12 b .67 ± _43b 63a 37a 
Fo ate/Vitamin C .84 ± . 73a, b .39 ± .26a, I. 23 ± . gga' b 64a 36a 
Table 3. (Continued) 
µq Hq/q wet tissue 
Treatment Inorganic Hg Methyl Hg Total Hg % Inorganic % Methyl 
Lungs 
1.14 ± .22~,b 55a,b 35a,b Controls .74 ± .I8a .40 ± .01a 
B12/Folate . 69 ± .18a .40 ± .01a 1.10 ± .19 53b 37a 
Spleen 
.89 ± .51~,b .59 ± .2oa,b 1.48 ± .69a,b,c 5aa,b 42a,b Controls 
812/Fo late .70 ± .13 .54 ± .05a,b 1.24 ± .11a,b 55b 44a 
B1(Vitamin C 1. 42 ± 1. ooa, ~ .76 ± .46b,c 2.18 ± l.46b,c 54a 35b 
Fo ate/Vitamin C 1.39 ± 1.oaa, .67 ± .37a,b,c 2.06 ± l.45a,b,c 55a 35b 
U'1 
U'1 Kidney 
Controls 19.17 ± 2.49a,b 14.72 ± 2.11a,b 33.89 ± 4.49a,b,c 57a 43a 
B12/Folate 20.46 ± 2.43a 16.92 ± 1.61c 37.38 ± 4.0lc 55a,b 45a,b 
B1(Vitami n C 17.91 ± .56a,b 14.11 ± .a2a,b 32.02 ± l.33a,b 55a,b 44a,b 
Fo ate/Vitamin C 18.30 ± 2.ooa,b 14.77 ± 1.42a,b 33.07 ± 3.3oa,b,c 55a,b 45a,b 
Hair 
Controls .80 ± .26a .65 ± .23a b 1.44 ± .46a b 55a 45a 
B12/Folate .87 ± .2oa .78 ± .o8a, .165 ± .25a, 53a 47a 
Blood (µg Hg/ml) 
.19 ± .04a,b .37 ± .09~,b Controls .18 ± .o5a b 53a 47a 
B12/Folate .18 ± .o3a .17 ± .02a, .35 ± .03 51a 49a 
Values represent the average± S.D. Data sharing a common subscript letter in a column are not 
significantly different (p > 0.05). 
methylmercury compared to controls and the other vitamin combinations. 
The percent inorganic mercury also reflected this difference. 
Controls were not statistically different from all the vitamin 
combinations for inorganic, methyl, and total mercury concentrations in 
the heart. However, the B12/folate group had a significantly higher 
percent methyl (52%) measurement compared to controls (37%), the 
B12/vitamin C group (37%) and the folate/vitamin C group (36%). A trend 
was noted in this tissue in which the two B12 groups exhibited the 
lowest mercury concentrations (inorganic, methyl, and total), while the 
folate/vitamin C group tended to have the highest concentrations. 
Only one vitamin combination was studied in lung tissue. There was 
no difference in mercury concentrations or percent mercury with 
B12/folate compared to controls. 
In the spleen, no difference was observed between the controls and 
.the various vitamin combinations for mercury concentration and percent 
mercury. The B12/folate group had significantly higher percent 
methylmercury (44%) compared to the B12/vitamin C (36%) and 
folate/vitamin C groups (35%). Interestingly, the two vitamin C groups 
exhibited a trend of higher mercury concentrations and percent inorganic 
mercury as compared to controls and the B12/folate group. 
In the kidney, no difference in inorgan~c mercury and percent 
mercury was shown for the vitamin combinations and controls. The 
B12/folate group had a significantly higher methylmercury concentration 
(16.92 µg) than control (14.72 µg), B12/vitamin C (14.11 µg), and 
folate/vitamin C (14.77 µg) groups. In addition, the B12/folate group 
had significantly more total mercury (37.38 µg) compared to the 
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B12/vitamin C group {32.02 µg). While this group exhibited an apparent 
increase in total mercury as compared to controls {33.89 µg) and the 
folate/vitamin C group {33.07 µg), this difference was not statistically 
significant. 
Hair and blood were evaluated for the control and B12/folate groups. 
Mercury concentrations and percent mercury were not significantly 
different in either of these tissues for the two groups. 
Controls vs Individual Vitamin Treatment 
The results from the experiments done to examine the effect of 
megadoses of B12 , folate, or vitamin Con mercury metabolism are shown 
in Table 4. In animals treated with the vitamins separately, the 
concentrations of all forms of mercury in the liver were significantly 
higher than the controls. Additionally, the percent methylmercury was 
greater {p < 0.05) in the B12 only, folate only, and vitamin Conly 
treated groups compared to controls. The percent inorganic mercury was 
lower in the individual vitamin groups compared to controls and this 
difference was statistically significant. 
In muscle there was no statistical difference in mercury 
concentrations {inorganic, methyl, and total) between the vitamin 
treated groups and controls. However, in the vitamin C group, the 
percent inorganic mercury was higher and percent methyl lower than 
control animals. These differences were statistically significant. 
There was also a tendency for the vitamin treated animals to have lower 
concentrations of all forms of mercury. 
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Table 4. Mercury Levels in Various Tissues of Guinea Pigs with the Individual Vitamin Dietary Regime 
µg Hg/g wet tissue 
Treatment Inorganic Hg Meth~l Hg Total Hg % Inorganic % Meth~l 
Liver 
Controls .78 ± .28a,b .37 ± .20a 1.15 ± .46a,b 69a 31a 
B1t 1. 58 ± . 20c 1.16 ± . 40c 2.74 ± _57c 59c 41c Fo ate 1. 60 ± . 71 C 1. 22 ± . 27c 2.83 ± .90C 55c 44c 
Vitamin C 1.72 ± .54c 1. 08 ± . J 9C 2.79 ± .54c 51b,c 39b,c 
Muscle 
Controls .21 ± .27a .18 ± .14a .39 ± .38a 51a,b,c 49a,b,c 
B1t .18 ± .o4a .14 ± .02a .32 ± .o4a 55a,c,d 45a,c,d 
0, Fo ate .15 ± . 04a .10 ± .o4a .25 ± .o7a 6QC,d 4oa,d 
co Vitamin C .16 ± .o3a .07 ± .02a .24 ± .o3a 69d 31d 
Brain 
Controls .30 ± .17a .24 ± .15a .54 ± .3la 55a,b 44a,b 
B1t .27 ± .04a .19 ± .o3a .46 ± .o3a saa,b 42a,b Fo ate .30 ± .osa .18 ± .02a .48 ± .o4a 53a 37b 
Vitamin C .23 ± .o3a .19 ± .02a .42 ± .o4a 55a,b 44a,b 
Heart 
Controls .72 ± .61a,b .35 ± .19a,b 1.07 ± .76a,b 53a 37a 
B1t .32 ± .o4b .17 ± .04b .so± .o6b 55a 35a Fo ate .31 ± .o6b .13 ± .01b .45 ± .osb 70a 30a 
Vitamin C .28 ± .o6b .14 ± .04b .42 ± .o6b 66a 34a 
Lungs 
1.14 ± .22a,b 55a,b 35a,b Controls .74 ± .18a .40 ± .o7a 
B1t 1.01 ± .3ob . 42 ± .10a 1.43 ± .38a 7oc,d 3oc,d Fo ate .86 ± .10a,b .32 ± .o3a 1.18 ± .12a,b 73d 27d 
Vitamin C .90 ± .2sa,b .40 :t .lla 1.29 ± _35a,b 69a,b,c 31 b,c,d 
<.11 
\0 
Table 4. (Continued) 
µg Hg/g wet tissue 
Treatment Inorganic Hg Meth~l Hg Total Hg % Inorganic % Meth~l 
Spleen 
.89 ± .51a,b .59 ± .2oa,b 1.48 ± .69a,b,c 58a,b 42a,b Controls 
B1f 1.73 ± .53a .91 ± .18~ 2. 64 ± . 70c 55a 35b Fo ate 1.39 ± .98a,b .81 ± .24 ,c 2.21 ± 1.22b,c 5oa,b 4oa,b 
Vitamin C l.75±1.16a .93 ± .35c 2. 68 ± 1. 51 C 53a,b 37a,b 
Kidney 
19.17 ± 2.49a,b 14.72 ± 2.16a,b 33.89 ± 4.49a,b,c Controls 57a 43a 
B1f 19.08 ± l.65a,b 15.84 ± .34 ,c 34.91 ± l.9oa,b,c 54b 45b Fo ate 18.60 ± l.69a,b 15.57 ± .88b,c 34.16 ± 2,54a,b,c 55b 45b 
Vitamin C 20.12 ± .88a 15.94 ± .67b,c 36.07 ± 1.11b,c 55a,b 44a,b 
Hair 
Controls .80 ± .26a .65 ± .23a 1.44 ± ,47a . 55a 45a 
B1f .95 ± .32a 1.27 ± .63a,b,c 2.22 ± .87a,b,c 44a,b 55a,b Fo ate .95 ± .2oa 1. 84 ± 1. 3gc 2. 79 ± 1. 35c 40b 60b 
Vitamin C .95 ± _34a 1.47 ± .88 ,c 2.43 ± ,93b,c 43a,b 57a,b 
Blood (µg Hg/ml) 
.37 ± .09a,b Controls .19 ± .04a,g .18 ± . 05a 53a 47a 
B1f .24 ± .05a, .15 ± .02a,b .38 ± .07a,b 61b 39b Fo ate .20 ± .02a,b .13 ± .01b .33 ± .02b 60b 40b 
Vitamin C .28 ± .04b .16 ± .01a,b .44 ± .osa 54a 35b 
Values represent the average± S.D. Data sharing a common subscript letter in a column are not 
significantly different (p > 0.05). 
No difference in mercury concentrations and percent mercury was 
observed with vitamin treatment in the brain tissue compared to 
controls. However, there was a tendency for the vitamin groups to have 
lower concentrations of mercury. 
The heart also did not exhibit a statistically significant 
difference in mercury concentration or percent mercury between the 
vitamin treated groups and controls. However, the concentration of 
inorganic, methyl, and total mercury tended to be quite a bit lower in 
the vitamin treated animals than controls. 
The vitamin 812 group had significantly higher inorganic mercury 
levels than controls (1.01 µg vs .74 µg respectively) in lung tissue. 
This was reflected also in a higher percent inorganic mercury (70%) and 
lower percent methyl (30%) for 812 animals versus controls (65% 
inorganic, 35% methyl). These differences were statistically 
significant. Additionally, when expressed as percent the folate group 
had significantly mo~e inorganic (73%) and significantly less methyl 
(27%). 
While the individual vitamin treated animals tended to have higher 
inorganic, methyl, and total mercury concentrations than controls in the 
spleen, these measurements were not statistically different. Also, the 
percent inorganic mercury tended to be elevated in vitamin treated 
animals, but was not statistically different from controls. 
In the kidney there was no difference in mercury concentrations 
with vitamins given separately. These animals tended to show increased 
methylmercury and total mercury concentrations when compared to 
controls. The 812 group and folate group had significantly larger 
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percents of mercury present as methylmercury (46% and 45% respectively) 
compared to controls (43%). 
The concentration of inorganic mercury was not statistically 
different for the vitamin group compared to controls for hair samples. 
Although these groups tended to have higher methylmercury concentrations 
than controls, only the folate and vitamin C groups had significantly 
higher. Additionally, only the folate group had significantly more 
mercury as percent methyl (60%) compared to controls (45%). However, 
the 812 (56%) and vitamin C groups (57%) appeared higher than controls. 
These differences were inversely reflected in the percent inorganic 
mercury. 
In the blood there was no difference in concentration for all forms 
of mercury, but the vitamin treated animals exhibited an apparent 
increase in inorganic mercury concentrations and lower methylmercury 
concentrations compared to controls. When expressed as percent, the 
vitamin treated groups had significantly more inorganic mercury 
(812 = 61%, folate = 60%, and vitamin C = 64%) than controls (53%) 
and less methylmercury. 
Accumulated Guinea Pig Data 
The data from all the various vitamin treatments compared to 
controls are displayed by tissue in Tables 5 - 13. In the liver the 
individual vitamin treated groups had significantly more inorganic, 
methyl, total and percent methylmercury than controls and all other 
treated groups. The 812/folate group had significantly more inorganic 
mercury than the all vitamin and 812/vitamin C groups. Of importance, 
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Table 5. Mercury Levels in the Liver Tissue of Guinea Pigs with Different Vitamin Dietary Regimes 
µg Hg/g wet tissue 
Treatment Inorganic Hg Meth~l Hg Total Hg % Inorganic % Meth~l 
Controls .78 ± .28a,b .37 ± .20a 1.15 ± .46a,b 69a 31a 
n=18 
A 11 Vitamins .52 ± .12b .25 ± .o3a .77 ± .14b 67a,b 33a,b 
n=8 
812/Folate 1.05 ± .2sa .67 ± .ogb 1. 72 ± .33a 6ob,c 4ob,c 
n=5 
O'I 812/Vitamin C .61 ± .ogb .27 ± .o4a . 88 ± .13b 69a 31a N 
n=4 
Folate/Vitamin C . 78 ± .10a, b .38 ± .01a 1.15 ± .10a,b 67a,b 33a,b 
n=5 
B12 Only 1. 58 ± . 20c 1.16 ± . 40c 2.74 ± .57c 59c 41c 
n=5 
Folate Only 1. 60 ± . 71 C 1.22 ± .27c 2.83 ± .9QC 56c 44c 
n=5 
Vitamin C Only 1.72 ± .54c 1. 08 ± .19c 2.79 ± .54c 6Ib,c 39b,c 
n=5 
Values represent the average± S.D. Data sharing a common subscript letter in a column are not 
significantly different (p > 0.05). 
Table 6. Mercury Levels in the Muscle Tissue of Guinea Pigs with Different Dietary Vitamin Regimes 
µg Hg/g wet tissue 
Treatment Inorganic Hg Meth~l Hg Total Hg % Inorganic % Meth~l 
Controls .21 ± .21a .18 ± .14a .39 ± .38a 51a,b,c 49a,b,c 
n=l8 
All Vitamins .10 ± .02a .13 ± .o9a . 23 ± .10a 47a,b,c 53a,b,c 
n=8 
812/Folate .12 ± .o3a .19 ± . 04a .31 ± .o4a 39b 61b 
n=5 
O"\ 812/Vitamin C .27 ± .29a . 31 ± . l 9a .58 ± .45a 43a,b 57b,c w 
n=4 
Folate/Vitamin C 1. 33 ± 1. 60b .83 ± .83b 2.16 ± 2.40b 50a,b,c 5oa,b,c 
n=5 
812 Only .18 ± .o4a .14 ± .02a .32 ± .o4a 55a,b,d 45a,b,d 
n=5 
Folate Only .15 ± .o4a .10 ± .o4a .25 ± .01a 60c,d 4oa,d 
n=5 
Vitamin C Only .16 ± .o3a .07 ± .02a .24 ± .o3a 59d 31d 
Values represent the average± S.D. Data sharing a common subscript letter in a column are not 
significantly different (p > 0.05). 
Table 7. Mercury Levels in the Brain Tissue of Guinea Pigs with Different Vitamin Dietary Regimes 
ug Hg/g wet tissue 
Treatment Inorganic Hg Meth1l Hg Total Hg % Inorganic % Meth1l 
Controls . 30 ± .17a .24 ± .15a .54 ± .31a 55a,b 44a,b 
n=18 
All Vitamins .19 ± .o6a .18 ± . 07a .37 ± .11a 51b 49a 
n=8 
812/Folate 
n=5 
.16 ± .02a .15 ± . 03a .31 ± .04a 51b 49a 
°' 812/Vitami n C .20 ± .o8a .29 ± .14a .49 ± .22a 41c 59c ..,:::. 
n=4 
Folate/Vitamin C .25 ± .oga .18 ± .oga .43 ± .14a saa,b 42a,b 
n=5 
812 Only .27 ± .o4a .19 ± • 03a .46 ± .o3a 5aa,b 42a,b 
n=5 
Folate Only .30 ± .osa .18 ± .02a .48 ± .o4a 63a 37b 
n=5 
Vitamin C Only .23 ± .o3a .19 ± .02a .42 ± .o4a 56a,b 44a,b 
n=5 
Values represent the average± S.D. Data sharing a common subscript letter in a column are not 
significantly different (p > 0.05). 
Table 8. Mercury Levels in the Heart Tissue of Guinea Pigs with Different Vitamin Dietary Regimes 
u g Hg/g wet tissue 
Treatment Inorganic Hg Meth~l Hg Total Hg % Inorganic % Meth~l 
Controls .72 ± .61a,b .35 ± .19a,b 1.07 ± .76a,b 63a 37a 
n=18 
A 11 Vitamins 1.29 ± .91a .60 ± .33a 1.90 ± 1.24a 66a 34a 
n=B 
B12/Folate .26 ± .03b .33 ± .19b .59 ± .2ob 4ab 52b 
n=5 
°' B12/Vitami n C .44 ± .31b .23 ± .12b .67 ± .43b 63a 37a (J1 
n=4 
Folate/Vitamin C .84 ± .74a,b .39 ± .26a,b 1. 23 ± . gga' b 64a 36a 
n=5 
B12 Only .32 ± .o4b .17 ± . 04b .5o ± .o6b 65a 35a 
n=5 
Folate Only .31 ± .o6b .13 ± .01b .45 ± .o5b 70a 30a 
n=5 
Vitamin C Only .28 ± .o6b .14 ± .o4b .42 ± .o6b 66a 34a 
n=5 
Values represent the average± S.D. Data sharing a common subscript letter in a column are not 
significantly different (p > 0.05). 
Table 9. Mercury Levels in the Lung Tissue of Guinea Pigs with Different Vitamin Dietary Regimes 
ug Hg/g wet tissue 
Treatment Inorganic Hg Meth~l Hg Total Hg % Inorganic % Meth~l 
Controls .74 ± .I8a .40 ± .01a 1.14 ± .22a,b 6sa,b 35a,b 
n=13 
A 11 V it am i n s .82 ± .16a,b .41 ± .01a 1.23 ± .21a,b 67a,b,c 33a,b,c 
n=8 
812/Folate .69 ± .12a .40 ± .o9a 1.10 ± .19b 63b 37a 
n=5 
°' 812 Only 1.01 ± .Job .42 ± .10a 1.43 ± .38a 70c,d 3oc,d 
°' n=5 
Folate Only .86 ± .10a,b .32 ± .o3a 1.18 ± .12a,b 73d 27d 
n=5 
Vitamin C Only .90 ± .2sa,b . 40 ± .11 a 1.29 ± _35a,b 69a,c,d 31b,c,d 
n=5 
Values represent the average± S.D. Data sharing a common subscript letter in a column are not 
significantly different (p > 0.05). 
Table 10. Mercury Levels in the Spleen Tissue of Guinea Pigs with Different Vitamin Dietary Regimes 
µg Hg/g wet tissue 
Treatment__ Inorganic Hg Meth~l Hg Total Hg % Inorganic % Meth~l 
Controls .89 ± .51a,b .59 ± .2oa,b 1.48 ± .69a,b,c 58a,b 42a,b 
n=l8 
A 11 Vitamins . 52 ± .10b .41 ± .10a . 93 ± .18a 56b 44a 
n=8 
812/Folate . 70 ± .13b .54 ± .05a,b 1.24 ± .11a,b 56b 44a 
n=5 
O'I 812/Vitamin C 1.42 ± 1.ooa,b .76 ± .46b,c 2.18 ± l.46b,c 64a 36b ""'-J 
n=4 
Fol ate/Vitamin C 1.39 ± 1.oaa,b .67 ± _37a,b,c 2.06 ± 1_45a,b,c 65a 35b 
n=5 
B12 Only 1. 73 ± • 53a .91 ± .I8c 2.64 ± .1oc 65a 35b 
n=5 
Folate Only 1.39 ± .9aa,b .81 ± .24b,c 2.21 ± 1.22b,c 6oa,b 4oa,b 
n=5 
Vitamin C Only 1.75 ± 1.16a .93 ± _35c 2. 68 ± 1. 51 C 63a,b 37a,b 
n=5 
Values represent the average± S.D. Data sharing a common subscript letter in a column are not 
significantly different (p > 0.05). 
Table 11. Mercury Levels in the Kidney Tissue of Guinea Pigs with Different Vitamin Dietary Regimes 
ug Hg/g wet tissue 
Treatment_ Inorganic Hg Meth~l Hg Total Hg % Inorganic % Meth~l 
Controls 19.17±2.49a,b 14.72 ± 2.11a,b 33.89 ± 4_49a,b,c 57a 43a 
n=l8 
A 11 Vitamins 16.96 ± _75b 13.46 ± .8oa 30.42 ± 1.44a 55a,b 44a,b 
n=8 
B12/Folate 20.46 ± 2.43a 16.92 ± 1.61c 37.38 ± 4.0lc 55a,b 45a,b 
n=5 
O'I B12/Vitami n C 17. 91 ± . 55a, b 14.11 ± .82a,b 32.02 ± 1.33a,b 55a,b 44a,b CX> 
n=4 
Folate/Vitamin C 18.30 ± 2.ooa,b 14.77 ± 1.42a,b 33.07 ± 3.3oa,b,c 55a,b 45a,b 
n=5 
812 Only 19.08 ± l.6sa,b 15.84 ± _34b,c 34.91 ± l.9oa,b,c 54b 45b 
n=5 
Folate Only 18.60 ± l.69a,b 15.57 ± .88b,c 34.16 ± 2.s4a,b,c 55b 45b 
n=5 
Vitamin C Only 20.12 ± .8aa 15.94 ± .67b,c 36.07 ± 1.17b,c 55a,b 44a,b 
n=5 
Values represent the average± S.D. Data sharing a common subscript letter in a column are not 
significantly different (p > 0.05). 
Table 12. Mercury Levels in the Hair Tissue of Guinea Pigs with Different Vitamin Dietary Regimes 
ug Hg/g wet tissue 
Treatment Inorganic Hg Methyl Hg Total Hg % Inorganic % Methyl 
Controls .80 ± .26a .65 ± .23a 1.44 ± .47a 55a 45a 
n=l3 
A 11 Vitamins .73 ± .33a .70 ± .2sa,b 1.43 ± .48a 51a,b 49a,b 
n=8 
812/Folate .87 ± .2oa .78 ± .o8a,b 1.65 ± .25a,b 53a 47a 
n=5 
°' 
812 Only .95 ± .32a 1.27 ± .63a,b,c 2.22 ± .81a,b,c 44a,b 55a,b ~
n=5 
Folate Only .95 ± .2oa 1.84 ± 1.38c 2. 79 ± I. 36c 40b 50b 
n=5 
Vitamin C Only .95 ± .34a 1. 41 ± . 99b, c 2.43 ± _93b,c 43a,b 57a,b 
n=5 
Values represent the average± S.D. Data sharing a common subscript letter in a column are not 
significantly different (p > 0.05). 
Table 13. Mercury Levels in the Blood Tissue of Guinea Pigs with Different Vitamin Dietary Regimes 
µg Hg/ml 
Treatment Inorganic Hg Meth:il Hg Total Hg % Inorganic % Meth:il 
Controls .19 ± • 04a, b .18 ± .o5a .37 ± .oga,b 53a 47a 
n=5 
812/Folate .18 ± .o3a .17 ± 02a,b .35 ± .o3b 51a 49a 
n=5 
812 Only 
n=5 
. 24 ± • 05a, b .15 ± .02a,b .38 ± .01a,b 61b 3gb 
-....J Folate Only .20 ± .02a,b .13 ± .01b .33 ± .02b 60b 40b 
0 n=5 
Vitamin C Only .2a ± .o4b .16 ± .01a,b .44 ± .o5a 64b 36b 
n=5 
Values represent the average± S.D. Data sharing a common subscript letter in a column are not 
significantly different (p > 0.05). 
are the data showing that the 812/folate group (.67 µg) had a 
significantly higher methylmercury concentration than the control (.37 
µg), all vitamin (.25 µg), 812/vitamin C (.27 µg), and folate/vitamin C 
(.38 µg) groups. This difference is portrayed in the percent 
methylmercury data with the B12/folate group having significantly more 
as percent methylmercury compared to controls and the 812/vitamin C 
group. 
Table 6 shows the data for muscle tissue. The folate/vitamin C 
group had higher (p < 0.05) concentrations of all three forms of mercury 
compared to all other groups. However, the greatest percent 
methylmercury level observed was 61% in the 812/folate group, which was 
significantly different from the B12 , folate, and yitamin C groups. 
Also the vitamin C group had significantly less mercury as percent 
methylmercury (31%) compared to all the other groups, except the B12 and 
folate groups. 
The data for the brain tissue are shown in Table 7. There were no 
differences in the various mercury concentrations for all treatments 
versus controls. However, the B12/vitamin C group did have a 
significantly higher proportion of mercury as methylmercury (59%) 
compared to controls (44%) and other vitamin treatments. A trend was 
also evident in that the groups treated with B12 and some combination 
(all vitamin, B12/folate, or B12/vitamin C) had a higher proportion of 
methylmercury values than controls. The individual vitamins and 
fol ate/vitamin C groups all had lower percent methyl values than 
controls. 
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In the heart (Table 8) there were no differences between controls 
and the various vitamin treated groups. However, the all vitamin group 
did have mercury concentrations which were significantly higher than the 
other vitamin treated groups, except the folate/vitamin C group. 
Furthermore, the 812/folate group had proportionately more methylmercury 
(52%) than controls (37%) and the other vitamin treated groups. 
Data for lung tissue (Table 9) were fairly consistent between 
groups; however, the 812 group had an inorganic mercury level (1.01 µg) 
which was significantly greater than controls (.74 µg) and the 
812/folate group (.69 µg). Methylmercury concentrations were not 
significantly different between groups. Although the B12 group had 
significantly more (1.43 µg) total mercury than the B12/folate group 
(1.10 µg), both the B12 and folate groups had proportionately less 
mercury as methylmercury (30% and 27% respectively) than controls (35%) 
and the 812/folate group (37%). 
Inorganic and total mercury concentrations for the vitamin treated 
groups were not statistically different from control animals in the 
spleen (Table 10). The B12 and vitamin C groups did have inorganic and 
total mercury concentrations which were greater (p < 0.05) than the all 
vitamin group and the 812/folate group. Also, the B12 and vitamin C 
groups had significantly higher methylmercury levels than controls, the 
all vitamin, and B12/folate group. Both the all vitamin and B12/folate 
groups had 44% methylmercury levels which were statistically different 
from the 812/vitamin C group (36%), folate/vitamin C group (35%) and the 
812 only group (35%). 
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Table 11 contains data for kidney tissue. The vitamin treated 
groups were not statistically different in inorganic and total mercury 
concentrations compared to controls. The 812/folate and vitamin C 
groups had significantly more inorganic and total mercury than the all 
vitamin group. Additionally, methylmercury concentration in the 
812/folate group (16.92 µg) was significantly higher than controls 
(14.72 µg) and the all vitamin (13.46 µg), 812/vitamin C (14.11 µg) and 
folate/ vitamin C (14.77 µg) groups. The all vitamin group had the 
lowest mercury concentrations of all groups while the 812/folate group 
had the highest concentrations. Percent methyl values in the B12 and 
folate groups (46% and 45% respectively) were significantly higher than 
controls (43%). 
In hair tissue (Table 12), inorganic mercury concentration did not 
differ among the groups. Both the folate group and vitamin C group had 
methyl and total mercury concentrations which were significantly higher 
than controls. Of interest also was the fact that the folate group had 
significantly more methyl and total mercury than the all vitamin and 
B12/folate groups. While the vitamin treated groups all tended to have 
higher percent methylmercury levels than controls, only the folate group 
(60%) was significantly higher than controls (45%) and the 812/folate 
group (47%). 
The data for the blood sample are shown in Table 13. Inorganic 
mercury data indicated that the vitamin C group (.28 µg) was 
significantly higher than the 812/folate group (.18 µg) but these groups 
were not different from controls. Methylmercury concentration in the 
folate group (.13 µg) was significantly lower than controls (.18 µg). 
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For total mercury concentration, only the vitamin C group (.44 µg) was 
significantly different than the B12/folate group (.35 µg) and folate 
group (.33 µg). The three groups treated with individual vitamins all 
had percent methylmercury values which were significantly lower than the 
controls and B12/folate group. 
Rats Treated With Cysteine or Methionine 
Six tissues were analyzed in rats to examine the effect of cysteine 
or methionine supplemented diet regimes on mercury metabolism. These 
data were compared to control animals fed a normal dietary regime. The 
results of this experiment are shown in Tables 14 - 19. 
The data from the liver tissue are shown in Table 14. There was a 
general trend for the methionine group to have the lowest concentrations 
of all three forms of mercury. For example, the methionine group had an 
inorganic mercury level of 1.39 µg compared to the controls (2.02 µg) 
and the cysteine group (1.89 µg). Methylmercury measurements were .79 
µg for the methionine group, .92 µg for controls, and 1.07 µg for the 
cysteine group while total mercury levels were 2.18 µg, 2.93 µg, and 
2.96 µg for the methionine, controls and cysteine groups, respectively. 
However, these differences were not statistically different from control 
animals. Both the methionine and cysteine groups exhibited percent 
methyl values which were significantly higher than controls (36% for 
both vs 32% for controls). 
In brain tissue neither mercury concentration or percent mercury 
did not differ for the methionine and cysteine groups from controls. 
Inorganic mercury data were very similar while the methyl and total 
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Table 14. Mercury Levels in the Liver Tissue of Rats with Methionine or Cysteine Supplemented Diets 
ug Hg/g wet tissue 
Treatment Inorganic Hg Meth~l Hg Total Hg % Inorganic % Meth~l 
Controls 2.02 ± .68a .92 ± .21a 2.93 ± .89a 68a 32a 
n=5 
Methionine 1.39 ± .1sa . 79 ± .11 a 2 .18 ± . 26a 64b 36b 
n=5 
Cysteine 1. 89 ± . 71 a 1.07 ± .33a 2. 96 ± 1. 03a 64b 36b 
n=5 
Values represent the average± S.D. Data sharing a common subscript letter in a column are not 
significantly different (p > 0.05). 
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Table 15. Mercury Levels in the Brain Tissue of Rats with Methionine or Cysteine Supplemented Diets 
ug Hg/g weLtissue 
Treatment Inorganic Hg Meth:il Hg Total Hg % Inorganic % Meth:il 
Controls .35 ± .o6a .27 ± .o5a .62 ± .oga 56a 44a 
n=5 
Methionine .36 ± .o5a .30 ± .o6a .67 ± .01a 55a 45a 
n=5 
Cysteine .36 .01a .32 ± .o5a .67 ± .oga 53a 47a 
n=5 
Values represent the average± S.D. Data sharing a common subscript letter in a column are not 
significantly different (p > 0.05). 
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Table 16. Mercury Levels in the Lung Tissue of Rats with Methionine or Cysteine Supplemented Diets 
µg Hg/g wet tissue 
. Treatment Inorganic Hg Meth~l Hg Total Hg % Inorganic % Meth~l 
Controls . 65 ± .18a .39 ± .oaa 1.04 ± .25a 62a 39a 
n=5 
Methionine .67 ± .11a .43 ± .oaa 1.10 ± .19a 61a 39a 
n=5 
Cysteine .64 ± .o5a .40 ± .o3a 1.03 ± .o6a 62a 39a 
n=5 
Values represent the average± S.D. Data sharing a common subscript letter in a column are not 
significantly different (p > 0.05). 
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Table 17. Mercury Levels in the Heart Tissue of Rats with Methionine or Cysteine Supplemented Diets 
µg Hg/g wet tissue 
Treatment Inorganic Hg Meth~l Hg Total Hg % Inorganic % Meth~l 
Controls . 52 ± .10a .30 ± .01a .82 ± .14a 54a 35a 
n=5 
Methionine . 53 ± .10a .34 ± .o6a .86 ± .15a 61a 39a 
n=5 
Cysteine .51 ± .12a .34 ± .o5a .85 ± .17a 59a 41a 
n=5 
Values represent the average± S.D. Data sharing a common subscript letter in a column are not 
significantly different (p > 0.05). 
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Table 18. Mercury Levels in the Spleen Tissue of Rats with Methionine or Cysteine Supplemented Diets 
µg Hg/g wet tissue 
Treatment Inorganic Hg Meth~l Hg Total Hg % Inorganic % Meth~l 
Controls 1.74 ± .36a . 99 ± .18a 2.73 ± .s1a 54a 35a 
n=5 
Methionine 1. 36 ± • 29a .86 ± .22a 2.22 ± .49a 61a 39a 
n=5 
Cysteine 1. 53 ± .1 sa 1.01 ± .01a 2.54 ± .19a 60a 40a 
n=5 
Values represent the average± S.D. Data sharing a common subscript letter in a column are not 
significantly different {p > 0.05). 
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Table 19. Mercury Levels in the Kidney Tissue of Rats with Methionine or Cysteine Supplemented Diets 
µg Hg/g wet tissue 
Treatment Inorganic Hg Methyl Hg Total Hg % Inorganic % Methyl 
Controls 18.70 ± 2.11a 14. 84 ± 1. 20a 33.54 ± 3.34a 55a 44a 
n=5 
Methionine 17.31 ± 1.73a 14.38 ± 1.33a 31.69 ± 3.o5a 55b 45b 
n=5 
Cysteine 16.89 ± 1. 10a 14.19 ± 1.42a 31. 08 ± 3 . 11 a 55b 45b 
n=5 
Values represent the average± S.D. Data sharing a common subscript letter in a column are not 
significantly different (p > 0.05). 
mercury measurements were slightly higher in the two treatment groups 
compared to controls. Also, percent methyl was highest in the cysteine 
group (47%) compared to the controls (44%) and methionine groups (45%). 
There were no differences between controls and the two treatment 
groups in the lungs for mercury concentrations or percent mercury. The 
methionine group did have the highest concentration values of all three 
groups. 
In heart tissue there were also no statistical differences in 
concentrations or percent mercury between groups. Again, the methionine 
group tended to exhibit the highest concentration values, yet the 
cysteine group had the highest percent methylmercury (41%) compared to 
controls (36%) and the methionine group (39%). 
In spleen tissue mercury concentrations and percent mercury were 
not statistically different for any of the groups. In fact, the 
concentration data from this tissue were very similar to the liver. The 
methionine group had the lowest values with inorganic at 1.36 µg, methyl 
at .86 µg, and total mercury at 2.22 µg. This compared to control 
inorganic mercury of 1.74 µg, methyl .99 µg, and total 2.73 µg, with the 
cysteine group having 1.53 µg inorganic, 1.01 µg methyl, and 2.54 µg 
total mercury. Additionally, both the methionine and cysteine groups 
had a higher percent methylmercury (39% and 40%, respectively) compared 
to controls (36%). 
The data from the kidney also showed no statistical differences in 
concentrations for the three groups. However, the methionine and 
cysteine groups both tended to have lower mercury concentrations. These 
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two groups did have percent methylmercury values which were 
statistically different from the control animals. 
Auditory Brainstem Response Data 
The auditory brainstem response (ABR) data for controls and the 
mercury treated groups by the different frequencies are shown in Tables 
20-23. The individual frequency means for each group are provided in 
Appendix 2. Guinea pigs which had been fed a control diet and had no 
exposure to mercury served as the control or untreated group. 
Recordings were obtained from this group and provided an example of 
normal guinea pig ABR measurements. These animals were then given 
subcutaneous injections of mercuric chloride (0.6 mg/kg body weight) 
every other day for a total of nine injections. At the end of mercury 
treatment, ABR recordings were obtained. This group was designated as 
the mercury only group and provided information on ABR dysfunction as a 
result of inorganic mercury intoxication. All vitamin groups received 
mercury treatment and were designated according to their respective 
vitamin regimes. ABR measurements from the vitamin groups with mercury 
treatment were subsequently compared to the recordings from the mercury 
only group. These data served to determine if a vitamin(s) had altered 
the mercury effect as measured by ABR. 
All animals exhibited a positive Preyer's reflex except for three 
animals in the B12 group. By visual inspection, the ABR measurements 
for these animals correlated to the Preyer's reflex observations with 
delayed latencies and increased thresholds exhibited in these animals. 
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Table 20. Auditory Brainstem Responses at 8K Frequency in Guinea Pigs with Mercury Treatment and 
Various Vitamin Regimes 
Treatment I Latency I Amp 1 itude II Latency I I Amp 1 itude V Latency 
{msec} { l! V} {msec} { !:!V) {msec} 
Untreated 
1.59 ± a,b .96 ± .s2a,b .52 ± .ssa,b Controls 2.43 ± .27a 3.91 ± .37a 
n;;lO 
Controls+ Hg 1.54 ± .2ob,c .87 ± .51a,b 2.42 ± .24a .51 ± _43a,b 3.95 ± .3la 
n;:;5 
s12/Folate + Hg 1.51 ± .2oc 1.05 ± .47a 2.41 ± .23a .57 ± .51a,b 3.90 ± .39a 
n;:;5 
812 + Hg 1.66 ± .29a .90 ± .46a,b 2.45 ± .26a .45 ± .34a,b 3.89 ± .32a 
n;:;5 
Folate + Hg 1.52 ± .21b,c .83 ± _44b 2.40 ± .22a .67 ± .44a 3.86 ± .32a 
n;:;5 
Vitamin C + Hg 1.60 ± .2oa,b .96 ± ,44a,b 2.38 ± .19a .43 ± .38b 3.85 ± .37a 
n;:;5 
--
V Amp 1 itude 
{ !:!V} 
.67 ± _54a,b 
.46 ± .4lc 
.76 ± .Goa 
.77 ± .6la 
.55 ± ,43b,c 
.76 ± .58a 
Values represent the average± S.D. for all intensities. Data sharing a common subscript letter in a column 
are not significantly different (p > 0.05). 
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Table 21. Auditory Brainstem Responses at 6K Frequency in Guinea Pigs with Mercury Treatment and Various Vitamin 
Regimes 
Treatment I Latency I Amplitude II Latency II Amplitude V Latency V Amplitude 
{msec} {µV} {msec} {µV} {msec} { l!V} 
Untreated 
1.68 ± .3oa b Controls .79 ± .55a 2.54 ± .3oa .45 ± .5la 4.03 .36a,b,c .54 ± .43a 
n=lO ' 
Controls+ Hg 1.67 ± .24a,b .65 ± .32a 2.59 ± .21a .36 ± .29a 4.12 ± ,39a,b .29 ± ,34b 
n=5 
812/Folate + Hg 1.68 ± .32a,b . 77 ± .48a 2.60 ± .3la .52 ± .48a 4.15 ± _53a .57 ± .45a 
n=5 
812 + Hg 1.73 ± .23a .73 ± .42a 2.54 ± .27a .47 ± .43a 3.96 ± .21c .63 ± .54a 
n=5 
Folate + Hg 1.61 ± .22b .68 ± .4oa 2.52 ± .26a .54 ± .48a 3.98 ± .20b,c .52 ± .36a 
n=5 
Vitamin C + Hg 1.71 ± .23a .66 ± .35a 2.50 ± .25a .35 ± .32a 3.92 ± .32c .57 ± .45a 
n=5 
--
Values represent the average± S.D. for all intensities. 
are not significantly different (p > 0.05). 
Data sharing a common subscript letter in a column 
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Table 22. Auditory Brainstem Responses at 4K Frequency in Guinea Pigs with Mercury Treatment and Various Vitamin 
Regimes 
Treatment I Latency I Amplitude II Latency I I Amplitude V Latency V Amplitude 
{msec} {µ V} {msec} {~ V} {msec} {~ V} 
Untreated 
Controls 1.79 ± .3Ia .92 ± .78a,b 2.64 ± .21a,b,c .61 ± .6aa,b,c 4.18 ± .36a .56 ± .45a 
n=lO 
Controls+ Hg 1.75 ± .24a .72 ± .66b,c 2.67 ± _32a,b,c .59 ± .69a,b,c 4.20 ± .33a .35 ± .Jab 
n=5 
81 2/Folate + Hg 1.76 ± .2aa 
n=5 
1.05 ± .78a 2.67 ± .29a,b .74 ± .86a,b 4.12 ± .27a .64 ± .5oa 
B12 + Hg 1.90 ± .27b .72 ± .5Ib,c 2.73 ± .3Ia .43 ± _53c 4.12 ± .26a .53 ± .46a,b 
n=5 
Folate + Hg 1.77 ± .27a .86 ± .69a,b,c 2.61 ± .25b,c .82 ± .83a 4.10 ± .20a .51 ± .41a,b 
n;:;:5 
Vitamin C +Hg 1.84 ± .29a,b .65 ± .sic 2.56 ± .24c .so± .ssb,c 4.07 ± .3la .52 ± _37a,b 
n=5 
--
Values represent the average± S.D. for all intensities. 
are not significantly different (p > 0.05). Data sharing a common subscript letter in a column 
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Table 23. Auditory Brainstem Responses at 2K Frequency in Guinea Pigs with Mercury Treatment and Various Vitamin 
Regimes 
Treatment I Latency I Amp 1 itude II Latency I I Amp 1 itude V Latency V Amp 1 itude 
{msec} { h! V} {msec} h!V} {msec} { !::!V} 
Untreated 
Controls 2.17 ± .3la .64 ± .4aa,b 3.06 ± .2aa .42 ± ,53a,b 4.52 ± .36a,b .36 ± .2aa 
n=lO 
Controls+ Hg 2.16 ± .21a .48 ± .42b 3.07 ± .3la .41 ± .56a,b 4.59 ± .27a .18 ± .13b 
n=5 
B12/Folate + Hg 2.08 ± .29a .70 ± .48a 3.03 ± .29a .52 ± ,44a,b 4.41 ± .3oa,b .39 ± .2aa 
N=5 
B12 + Hg 2.30 ± ,35b .52 ± .3aa,b 2.95 ± .3oa .49 ± .5aa,b 4.43 ± .3oa,b .31 ± .12a 
n=5 
Folate + Hg 2.11 ± .27a .60 ± .41a,b 2.93 ± .26a .63 ± .66a 4.46 ± .26a,b .39 ± .26a 
n=5 
Vitamin C + Hg 2.20 ± .29a,b .47 ± .26b 3.30 ± .33a .25 ± .25b 4.37 ± .29b . 32 ± .18a 
n=5 
--
Values represent the average± S.D. for all intensities. Data sharing a common subscript letter in a column 
are not significantly different (p > 0.05). 
At a frequency of 8k, several differences were observed. The 812 
group had a wave I latency of 1.66.msec. which was longer (p < 0.05) 
than the mercury only treated group (1.54 msec.). This increase in 
latency of wave I by the 812 group as compared to the mercury only group 
is depicted in Figure 5. Waves II and V latencies showed no differences 
between groups. 
The amplitude of wave I was lowest for the folate group which was 
different (p < 0.05) from the 812/folate group, but not the untreated 
control and mercury only groups. However, for wave II amplitude, the 
measurements were opposite from wave I. Although the folate group had 
the highest wave II amplitude (.67 µV) of all the groups, it was only 
statistically different from the vitamin C group (.43 µV). The wave V 
amplitude data indicated that the mercury only group had a lower (p < 
0.05) amplitude than untreated controls and all the vitamin groups 
except the folate group. 
At a frequency of 6k, wave I latencies were not significantly 
different between groups. However, the means for the 812 group and 
vitamin C group were longer than the mercury only treated group. Wave 
II latencies were not statistically different among the groups. Wave V 
latency data indicated that the 812 and vitamin C groups had latencies 
(3.96 msec. and 3.92 msec., respectively) which were different (p < 
0.05) than the mercury only group (4.12 msec.). 
The amplitudes for waves I and II were not different (p < 0.05) for 
all groups at the 6k frequency. The mercury only group generally had 
the lowest amplitude for these two waves and in wave V, this group had a 
amplitude (.29 µV) which was lower (p < 0.05) than the untreated 
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Tracings represent responses to 256 stimuli. Each 
trace was performed in duplicate. Vertical scale 
equal to .61 µV and horizontal to 1 msec. 
Figure 5. Latency alterations of Wave I at 8K frequency and 105 dB 
intensity for mercury only (A) and B12 animal (B). 
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control (.54 µV) and the vitamin treated groups. There was a trend for 
the vitamin groups treated with B12 and/or folate to exhibit higher 
amplitudes compared to the mercury only group. 
The B12 group had a wave I latency (1.90 msec.) that was longer (p < 
0.05) than untreated controls and the mercury only group (1.79 msec. 
and 1.75 msec., respectively) as well as the B12/folate group (1.76 
msec.) and folate group (1.77 msec.) at a frequency of 4k. While this 
group also had the longest latency (2.73 msec.) for wave II, it was not 
different (p < 0.05) from the mercury only group (2.67 msec.). The wave 
V latencies were not different (p < 0.05) among the groups; however, the 
means for the vitamin treated groups were shorter for wave V latencies 
than the untreated and mercury only groups. This was similar to the 8k 
frequency data for wave V latencies. 
The wave I amplitude measurements for the 4k frequency indicated 
that the B12/folate group had an amplitude (1.05 µV) which was higher (p 
< 0.05) than the mercury only and B12 groups (.72 µV). The wave II 
amplitude data showed no differences among groups. However, the B12 
group had the lowest mean for wave II amplitude, which was different (p 
< 0.05) than the 812/folate and folate groups, although not 
different from the mercury only group. It was observed that the two 
folate treated groups generally had higher amplitudes than the other 
groups. For wave V amplitudes, the mercury only group (.35 µV) again 
was lower (p < 0.05) than the untreated control (.56 µV) as well as the 
B12/folate groups (.64 µV). The alterations of wave amplitudes with 
mercury treatment are depicted in Figure 6 which compares a untreated 
control animal with a B12 treated animals. 
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Tracings represent responses to 256 stimuli. Each trace 
was performed in duplicate. Vertical scale is equal to 
.61 µV and horizontal scale equal to 1 msec. 
Figure 6. ABR wave amplitude alterations with mercury treatment in 
untreated controls (A) and vitamin 812 treated (8) animal 
at 4K frequency and 105 dB intensity. 
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The B12 group had a wave I latency which was longer (p < 0.05) than 
all other groups except the vitamin C group at the 2k frequency. 
However, the wave II latencies were not different (p < 0.05) between the 
various groups. The vitamin C group had a wave V latency (4.37 msec.) 
which was shorter {p < 0.05) than the mercury only group (4.59 msec.). 
Again, the means of the vitamin groups for wave V latencies were shorter 
than untreated controls and mercury only animals. 
The B12/folate group had a wave I amplitude (.70 µV) which was 
significantly higher than the mercury only group (.48 µV). The wave II 
amplitude data yielded no differences between the mercury only group and 
remaining groups. Once again, the wave V amplitude was most affected in 
the mercury only group, which was significantly lower (.18 µV) than the 
control and other treated groups. 
The data for the interpeak latencies (IPL) are shown in Table 24. 
The B12 group had IPL's which were shorter (p < 0.05) than controls and 
mercury only treated animals at Bk, 4k, and 2k frequencies. This 
group's IPL were also significantly shorter than the mercury only group 
at the 6k frequency. In addition, the B12 group exhibited IPL's which 
were shorter (p < 0.05) than the B12/folate group at all frequencies. 
Interpeak latencies in the vitamin C group were significantly shorter 
than all the other groups except the 812 group for all frequencies. In 
the 6k frequency, IPL's for the mercury only group (2.47 msec.) were 
longer {p < 0.05) than the untreated controls (2.35 msec.). 
In Table 25 the threshold data are presented. The B12 group had 
thresholds which were higher (p < 0.05) at Bk (70.0 dB) compared to the 
control (51.5 dB), mercury only (56.0 dB), and B12/folate (56.0 dB) 
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Table 24. 1-V Interpeak Latencies for ABR's at Various Frequencies in 
Guinea Pigs with Mercury Treatment and Various Vitamin 
Regimes 
SK 6K 4K 2K 
Treatment (msec) (msec) {msec) (msec) 
Untreated 
2.34a,b 2.3sa,b 2.4oa,b Controls 2.36a 
n=lO 
Controls+ Hg 2.42a 2.47c,d 2.46a 2.43a 
n=S 
812/Folate + Hg 2.4oa 2.49d 2.37a,b 2.33a 
n=S 
812 + Hg 2.24c 2.26b,e 2.24c 2.0gb 
n=S 
Folate + Hg 2.37a 2.37a,c 2.35b 2.37a 
n=S 
Vitamin C + Hg 2.26b,c 2.22e 2.2sc 2 .17b 
n=S 
Values represent the average for each group. Data sharing a 
common subscript letter in a column are not significantly different 
(p > 0.05). 
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Table 25. Threshold Values for ABR's at Various Frequencies in Guinea 
Pigs with Mercury Treatment and Various Vitamin Regimes 
8K 6K 4K 
GrOUQS (dB} (dB} (dB} 
Untreated 
Controls 51.5 ± 3.4a 58.5 ± 6.7a 57.0 ± 5.9a 69.0 
n=IO 
Controls + Hg 56.0 ± 2.2a 61.0 ± 4.2a,b 60.0 ± 3.sa,b 75.0 
n=5 
812/Folate + Hg 55.0 ± o.oa 60.0 ± 3.5a,b 53.0 ± 2.7a 66.0 
n=5 
812 + Hg 
n=5 
70.0 ± 16.2b 73.0 ± 17.9b 69.0 ± 17. 1 b 77 .0 
Folate + Hg 62.0 ± 5. 7a,b 66.0 ± 13_ 9a,b 60.0 ± 11.7a,b 74.0 
n=5 
Vitamin C + Hg 60.0 ± 3_5a,b 62.0 ± 5.7a,b 59.0 ± 4.2a,b 75.0 
n=5 
2K 
(dB} 
± 4.6a,b 
± 7.1a,b 
± 2.2b 
± 12.sa 
± 9. 5a' b . 
± 7.1a,b 
Values represent the average± S.D. for a 11 intensities. Data sharing a common 
subscript letter in a column are not significantly different (p > 0.05). 
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groups. Additionally, the 812 group had the highest thresholds at all 
frequencies compared to the remaining groups. Of particular interest is 
the fact that the 812 group had significantly higher thresholds than the 
812/folate group at the Bk, 4k and 2k frequencies. It also should be 
noted that at the 4k and 2k frequencies all the mercury treated groups 
had higher thresholds than the untreated control animals except the 
81/fo late group. 
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CHAPTER V 
DISCUSSION 
Mercury concentrations appeared to be lowered with the all vitamin 
treatment compared to controls in all tissues except for the heart and 
lungs while percent methyl mercury was increased. It is possible that 
with all three vitamins present at megadoses, these animals were able to 
detoxicate and excrete mercury more efficiently. It has been shown that 
bacteria and yeasts can detoxicate metallic mercury by first methylating 
it and then, demethylating it to elemental mercury, possibly by going 
through the mercurous form (110). It has been suggested that this 
biotransformation may also occur in humans, but the exact mechanism 
remains unclear (87). Therefore, since methylation possibly is the 
first step in the detoxication process, the animals with the all vitamin 
treatment may have been able to quickly methylate the mercuric chloride 
which is reflected in the increase in percent methylmercury values. The 
methylmercury was then further detoxicated and removed from the tissues, 
thus, leaving decreased tissue concentrations. The higher mercury 
concentrations in the lungs and heart with the all vitamin treatment may 
represent blood concentrations i.e. transport through the body for 
excretion. 
The next step in this investigation was to determine which 
vitamin(s) were playing a role in mercury metabolism. The 812/folate 
and 812/vitamin C groups seemed to exhibit the most activity in terms of 
methylmercury concentration and percent methylmercury. When compared to 
control animals, the B12/folate group had a higher methylmercury 
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concentration in the liver, kidney and hair and this difference was 
statistically significant in the liver and kidney. Additionally, an 
increased percent methylmercury content in all the tissues analyzed was 
observed in the 812/folate group when compared to controls, but this 
difference was only significant in the liver and heart. The 812/folate 
and 812/vitamin C groups both had the highest percent methylmercury 
values of all the groups in the muscle and brain. In fact, the 
812/vitamin C group was significantly higher than controls in the brain. 
It would appear that the two 812 combination groups (i.e. 812/folate, 
812/vitamin C) were similar to the all vitamin treated group in 
explaining the percent methylmercury data for the various tissues. 
Therefore, 812 apparently is the most important (the common denominator) 
vitamin in terms of increasing the percent methylmercury levels. 
Another interesting concept is evident from these data. The 
folate/vitamin C group exhibited an increase in mercury concentration 
(both inorganic and methyl) in the muscle and heart. The folate and 
vitamin Conly groups had increased concentrations in the lungs. 
Therefore, as observed in the all vitamin treatment group, folate and/or 
vitamin C appear to be the vitamins involved in increasing mercury 
concentrations in the heart and lung tissues. Also of interest with the 
vitamin combination groups, was the tendency for methylmercury to 
decrease proportionately even though the concentrations increased. This 
was also similar to the all vitamin group data. 
In order to isolate the specific vitamin activities in the various 
tissues, the vitamins were given separately. An increase in mercury 
concentrations was observed in the liver and spleen for all the 
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individual vitamins, but vitamin C exhibited the highest inorganic 
mercury values in these tissues compared to all the vitamin treated 
groups. Of particular interest was an increase in methylmercury 
concentration for the individual vitamin groups in the spleen, kidney, 
and hair. Also, with the individual vitamins, the percent methylmercury 
increased in the liver, kidney, and hair, but decreased in the muscle, 
brain, heart, lung, spleen, and blood. Of those tissues which exhibited 
an increase in percent methylmercury, the folate group showed the 
highest elevation in the liver and hair while the B12 group showed the 
highest elevation in the kidney. Furthermore, in those tissues with a 
decrease in percent methylmercury, the vitamin C group was lower (p < 
0.05) than controls in percent methylmercury in the muscle and blood. 
Therefore, it would again appear that 812 and/or folate play a role in 
methylation of mercury, while vitamin C may affect the increase in 
mercury concentrations, particularly inorganic mercury, and thus, result 
in a decrease in percent methylmercury. 
As these data began to accumulate, there were several tissues which 
presented unique information. First of all, the liver may be the most 
significant tissue in terms of the methylation process and eventual 
excretion. It possibly is the organ where the inorganic mercury is 
methylated and then "shipped out" for excretion. It has been proposed 
(64,87,110) that the methylation process is enzymatic and certainly the 
liver would be rich in enzyme systems. Also, as reported by Alexander 
and Aaseth (34), methylmercury apparently is transported from the liver 
to the kidney attached to glutathione. Since the liver is able to 
synthesize glutathione, it would support this concept of methylation and 
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excretion. When all the vitamins were given together, the liver's 
ability to methylate mercury was enhanced with subsequent export to the 
kidneys for excretion, thus, the mercury concentrations declined in the 
various tissues. Additionally, an increase in percent methylmercury was 
observed in most of the vitamin groups as compared to controls. This 
phenemenon may indicate that the liver is a site of methylation, but 
without all the vitamins present the process is slowed. 
The three groups treated with the individual vitamins had increased 
mercury concentrations. A possible explanation for this is that mercury 
accumulated due to the liver's inability to methylate it quickly and 
thus, get rid of it. This inability possibly is because all the 
necessary vitamins were not available at appropriate levels. 
The brain was an important tissue to investigate in this study 
since only the methylated form of mercury is able to cross the 
blood-brain barrier. Vitamin combinations which included B12 appeared 
to be the most effective in altering the percent methylmercury content 
in this tissue. Particularily significant is the B12/vitamin C group 
activity, which displayed the greatest increase in methylmercury 
concentration and percent methylmercury. This gives rise to an 
intriguing concept. Vitamin B12 and C may be acting synergistically in 
mercury metabolism. Hypothetically, vitamin C may in some way reduce 
the Co+3 to Co+2 so that folate is able to re-methylate the B12 by 
donating a free radical methyl (CH3.). The additional electron enables 
a carbanion (CH3-) to be released from 812 in order to methylate mercury. 
The 812 only group did not exhibit the same trends as the B12 combination 
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groups which may be due to a lack of contributing vitamins to 
re-methylate 812 • 
Hair tissue has long been recognized as an excellent indicator of 
methylmercury levels in the body. This is due to the sulfur containing 
protein, keratin, found in hair which readily binds to methylated 
mercury {13). Accordingly, the hair data from all the animals treated 
with vitamins seemed to support this concept. In each case the 
concentration and percent methylmercury increased with dietary intake of 
vitamins. The greatest increase occurred in those animals given folate 
only. This is similar to the data in the liver for the folate only 
group. Consequently, folate must be playing a role in the methylation 
of mercury either in combination with vitamin 812 or alone. 
As reported previously, folate {N5-methyltetrahydrofolate) can 
contribute a free radical methyl group to 812 {Co+2). However, this 
form of 812 theoretically cannot methylate mercury which requires a 
carbanion ion. As suggested earlier, vitamin C may act synergistically 
with 812 and folate resulting in the release of a carbanion from 812 and 
subsequent methylation of mercury. None of the diets in this study were 
deficient in any vitamin. Therefore, the folate group may have had 
sufficient levels of 812 and/or vitamin C to methylate the mercury and 
rapidly regenerate the proper form of 812 • Thi~ resulted in the high 
level of methylation exhibited in hair. 
Another hypothesis is proposed to explain the unexpected results 
displayed by the folate treated groups in this investigation. It may be 
possible that folate {N5-methyltetrahydrofolate) can contribute a 
carbanion {CH3-) and methylate mercury. For example, the N5-methyl THF 
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becomes desaturated at the 5,6 bond which results in the release of a 
carbanion group and the formation of dihydrofolate. This reaction is 
similar to that which occurs in thymidylate synthesis due to the 
activity of thymidylate synthetase. This would certainly explain the 
high level of methylated mercury which resulted in folate treated 
animals in the liver and hair. It may also be the reason for the high 
mercury concentrations observed in the muscle with folate/vitamin C 
treatment. 
Animals treated with vitamin C and/or some combination displayed 
conflicting data. Treatment with vitamin C by itself resulted in 
increased mercury concentrations, particularily inorganic, in the liver, 
spleen, kidney, hair and blood compared to controls. In muscle, the 
folate/vitamin C group had statistically significant increased mercury 
concentrations, while in the brain the B12/vitamin C group exhibited 
increased levels of methylmercury. A recent report {111) showed that 
the cupric {Cu++) form of copper was an efficient catalyst of ascorbate 
oxidation. It was suggested that in the presence of any transition 
metal, the oxidation of ascorbate can occur. Therefore, the mercuric 
ion may effectively oxidize ascorbate resulting in the reduction of 
mercury to the mercurous {Hg+) form. In this form, a free radical 
methyl group could bind to the mercury. This implies that N5-methyl THF 
could methylate the metal. Also, the mercurous form is known to be less 
toxic to mammals. In fact, mercurous has been used in the past by 
humans as a laxative and diuretic {112). This may explain the increased 
levels of inorganic mercury in certain tissues with vitamin C treatment 
or some combination thereof. 
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The muscle tissue provided data which indicated that the all 
vitamin or vitamin combination treatments resulted in an increase in 
percent methylmercury. With the exception of the folate/vitamin C 
group, the mercury concentrations were low and consistent among the 
various groups. Yet, there was an obvious increase in the percent 
methylmercury with vitamin treatment except in the individual vitamin 
groups. Methylmercury is lipid soluble and therefore, is more likely to 
be associated with lipid substances in the body. Since the muscle 
samples were not devoid of lipid, these data may be a reflection of 
lipid storage of mercury in the guinea pig. 
The heart, lungs, and spleen tissues generally provided data which 
may be influenced by the high degree of blood perfusion through these 
organs. The levels of mercury varied according to treatment and tissue 
but may reflect the ability of the tissue to concentrate mercury. The 
percent mercury data for the vitamin treated groups were consistent with 
or slightly lower than controls, except in the heart where the 
812/folate group was higher. However, this group had increased 
methylmercury in the liver, muscle, kidney, and hair. So the heart data 
may simply reflect the blood transport from or to these tissues in the 
treated animals. 
Since the kidney is an excretory organ, the data from this tissue 
would indicate the accumulation of mercury for excretion. The mercury 
concentration in the kidney was approximately 10-20 times higher than in 
any other tissue. It would be informative to measure urine excretion of 
mercury in order to determine the maximum clearance rate of mercury in 
these animals. However, in this investigation, it appears that the 
101 
kidneys did not lose their ability to concentrate mercury and thus, it 
is assumed the dose level of mercury given in this study was 
appropriate. 
ABR Testing 
The auditory brainstem response testing was performed in two groups 
of vitamin and mercury treated guinea pigs. Prior to mercury exposure, 
the control animals were tested to establish normal data. 
The ABR testing served two functions in this study. Thus far, no 
research has been done to investigate the effect of inorganic mercury 
treatment on guinea pig ABR. Therefore, this study was the first to 
examine the effect of inorganic mercury intoxication on the auditory 
system as evaluated by ABR data. Mercury treatment may result in 
peripheral damage and/or CNS alterations. Evidence has been presented 
to indicate damage by mercuric chloride to the sensory epithelium in the 
apical area (low frequency) of the guinea pig cochlea (113) and it has 
been shown to damage the mitochondria in hair cells and nerve terminals, 
which in turn results in impaired mitochondrial function, i.e. 
oxidative phosphorylation, calcium transport and phosphate accumulation 
was suppressed while ATP hydrolysis, potassium and magnesium transport 
were induced (114). Therefore, the mercuric chloride interferes with 
cell respiration and ATP synthesis which would delay signal 
transmission. However, in the present study, wave latencies across 
frequencies were not different for the mercury only treated animals 
compared to untreated controls. Thus, a large number of fast 
conducting, large diameter fibers have not been affected by mercury 
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treatment. In addition, IPL's were not significantly different in these 
two groups. This would suggest that impulse conduction time in the 
lower auditory centers and CNS has not been altered by inorganic mercury 
treatment regardless of frequency. 
However, treatment with inorganic mercury (mercury only group) 
resulted in a decrease in all wave amplitudes compared to untreated 
controls. This group exhibited a significantly lower wave V amplitude 
at all frequencies compared to untreated controls. Wave amplitude data 
are difficult to interpret due to the extreme variability among animal 
species. However, alterations in wave amplitudes can be due to damage 
of the peripheral or CNS auditory systems. If the damage occurs within 
the brainstem areas of the auditory system, it would be due to 
methylmercury toxicity since this is the only form of mercury which can 
cross the blood brain barrier. These animals were not deficient in any 
vitamin and thus, these data may simply represent a normal methylation 
process of inorganic mercury and subsequent transport into the.CNS. 
In order to determine if the decrease in wave amplitude was due to 
methylmercury damage of the auditory centers within the brainstem, the 
IPL data were examined. Research has demonstrated that methylmercury 
exposure results in shorter interpeak latencies (61). Yet, in the study 
reported here, the mercury only group exhibited IPL means which were 
longer than untreated controls. Furthermore, the wave V latency means 
for the mercury only group were longer than untreated controls while 
wave I latencies means were uneffected or slightly shorter than 
untreated controls. While these differences were not statistically 
significant, damage within the brainstem is indicated which supports the 
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concept that the inorganic mercury has been converted to methylmercury. 
Damage of the larger diameter or faster conducting fibers would result 
in longer interpeak latency values. Therefore, the decrease in wave 
amplitudes observed in mercury only treated animals would be due to 
signal transmission through the slower, small diameter fibers resulting 
in a decrease in nerve signal strength. 
Wave amplitudes can also be reduced when peripheral damage has 
occurred. Again, damage to the larger fibers would result in signal 
transmission through the smaller diameter fibers, and thus, a decrease 
in the strength of the action potential. Both inorganic mercury and 
methylmercury have been shown to cause damage to the cochlea hair cells 
and/or cochlear nerve. Thus, the data generated from the present 
investigation requires further research to determine the exact 
structures which are effected by the different forms of mercury. 
Second, this research appears to support the theory that vitamin 
B12 treatment may potentiate the mercury effect, particularily in the 
peripheral auditory system. The B12 only group had the greatest 
increase in wave I latency at every frequency for all groups tested. 
This group exhibited a significantly longer wave I latency at 8k, 4k, 
and 2k frequencies than the mercury only treated group. Since the other 
mercury treated groups were not statistically different from the mercury 
only group at each frequency, B12 appears to potentiate the mercury 
effects in the cochlea and/or cochlear nerve possibly due to its role in 
the methylation of mercury. 
According to the original hypothesis of this investigation, B12 
treatment should result in increased methylation of inorganic mercury. 
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With increased amounts of methylmercury available, the increased 
latencies may represent degeneration of hair cells in the base of the 
cochlea which has been demonstrated with methylmercury exposure (115). 
Methylmercury has also been shown to result in loss of cochlear 
microphonics and whole nerve action potentials (116) and this would be 
demonstrated by prolonged latencies in A8R testing. It has also been 
hypothesized that methylmercury exposure results in demyelination in the 
auditory nerve (57). Damage to the large fibers in the auditory nerve 
would impair rapid transients and result in longer wave I latencies. 
Therefore, the delayed latencies reported here indicates damage to the 
cochlea and/or cochlear nerve but the exact nature of the damage remains 
elusive. 
The idea that peripheral damage occurred due to increased 
methylmercury levels with 812 is supported by the threshold data. While 
all the mercury treated groups tended to exhibit an increase in 
threshold values compared to untreated controls, the 812 group produced 
the greatest increase in threshold intensity at all frequencies. The 
812 group had significantly higher threshold values than the untreated 
controls and mercury only group at the Bk frequency. These data 
indicate a high-frequency loss which would result from damage to the 
basilar membrane at the base of the cochlea. 
As noted earlier, mercuric chloride has been shown to result in 
damage to the apex area of the basilar membrane which would be 
demonstrated by a low frequency loss (57,58). Furthermore, research 
using methylmercury has shown a high frequency loss in mice (61). This 
suggests frequency-specific deficits to the lower auditory pathway 
105 
possibly due to the type of mercury. In this investigation, the high 
frequency loss would indicate damage due to methylmercury exposure. 
This possible nerve damage and subsequent increase in threshold value 
observed at the 8k frequency also supports research on high-frequency 
sensorineural deafness reported in 80% of the patients with 
methylmercury poisoning at Minamata Bay in the 1950's (117). 
B12/folate treatment did not appear to effect the wave I latencies, 
which is not consistent with the B12 group data. However, the 
B12/folate group did increase the amplitude of wave I at the 8k, 4k, and 
2k frequencies. Also this group and the folate group 
exhibited the greatest increase in amplitudes of wave II at all 
frequencies but these differences were not significant compared to 
untreated controls and the mercury only group. This alteration in wave 
amplitude certainly suggests that CNS function has been effected by 
these treatments. However, further analysis is necessary to establish 
if the wave latency (i.e. area under the specific wave) remains 
constant with each treatment. But, a decrease in wave amplitude would 
normally be expected if damage to the higher auditory centers within the 
brainstem has occurred. These data demonstrated an increase in 
amplitude which is difficult to explain. 
The possibility exists that with B12/folate treatment, an increased 
amount of methylmercury is produced. Methylmercury may cause impairment 
of slow conducting, small diameter fibers. This would result in a 
majority of transmission occurring from fast conducting, large diameter 
fibers, thus, the reduced dispersement of these fibers may produce a 
stronger impulse which may be demonstrated by elevated wave amplitudes. 
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Inspection of interpeak latencies values revealed shortened 
latencies for the B12 and vitamin C groups compared to the mercury only 
group. A probable explanation for these data can be obtained by 
examining latencies for waves I and V. The wave I latency means for 
these two groups were longer than the mercury only treated group at all 
frequencies. In addition, these groups exhibited wave V latency means 
which were shorter than the mercury only group. However, upon further 
inspection of the wave V latencies, it becomes apparent that the 
decrease in IPL's with vitamin treatment compared to the mercury only 
group is due to an increase in latency with mercury treatment. The 
vitamin treated groups exhibited wave V latency values which were very 
similar to the untreated controls. Therefore, this evidence clearly 
indicates that the increase in IPL with B12 and vitamin C treatment is 
due to a shift in wave I latency rather than an affect on nerve 
processes which regulate nerve conduction velocity in the CNS. The data 
from the 812 group can again be explained due to its role in methylation 
of mercury; however, an explanation for the vitamin C data remains 
unclear. It would appear that vitamin C potentiates the mercury affect 
in the auditory nerve possibly due to its oxidation/reduction potential. 
Methionine and Cvsteine Supplementation in Rats 
Since investigation of methylation processes of inorganic mercury 
was the intent of this research, a study was conducted in rats to 
examine the possible role of methionine as a methyl donor via S-
adenosylmethionine (SAM) transfer. Several points require 
clarification. First, SAM donates a carbonium (CH3+) group which 
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theoretically would not be the methyl form accepted by mercury (Hg++). 
However, SAM is involved in the regeneration of cobalt (Co+2) in B12 in 
those instances when the B12 becomes oxidized. Due to its role in B12 
metabolism, it would seem important to investigate SAM's effect on 
mercury methylation. Second, rats are able to synthesize vitamin C 
(118) and as demonstrated in the guinea pig data, vitamin C may play a 
role in mercury metabolism. In addition, these animals were given a 
diet sufficient in all vitamins including folate and B12 • Thus, rats 
may be able to alter the methylation of mercury due to their ability to 
make vitamin C available, as well as having sufficient dietary folate 
and B12 • Third, cysteine has been shown to result in decreased SAM 
concentrations in the rat liver (119). Also, a methionine-sparing 
effect has been demonstrated with cysteine supplementation (120). 
Therefore, a cysteine supplemented dietary regime was included in this 
study. 
The methionine treated group exhibited the lowest mercury 
concentrations of all three groups in the liver and spleen while having 
the highest concentrations in the lungs and heart. While there was an 
apparent increase in percent methylmercury in all tissues with 
methionine treatment compared to controls, this was only statistically 
different in the liver and kidneys. These data are very similar to the 
guinea pigs in the all vitamin group. It, again, raises the question 
that these animals can detoxicate the mercury more readily and excrete 
it from the body. Thus, the lowered concentrations are seen. Also, 
these data suggest that methionine is altering the mercury methylation 
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process since an increase in percent methyl is observed. This possibly 
is due to methionine's role in regenerating 812 • 
Those animals given the cysteine supplemented diets presented data 
which were slightly more complex. Assuming that cysteine can lower the 
liver concentration of SAM, it seems that these animals would exhibit a 
decrease in methylation potential. Yet, this group demonstrated the 
highest methylmercury concentrations in the liver, brain, and spleen as 
well as the highest percent methylmercury levels in the brain, heart, 
and spleen as compared to both the control and methionine treated 
groups. However, the cysteine group exhibited percent methylmercury 
values similar to the methionine group in the liver and kidneys which 
were the only measurements statistically different from controls. These 
data suggest that cysteine may also play a role in mercury methylation. 
A recent report {121) has shown that brain uptake of methylmercury 
is enhanced by chronic L-cysteine infusion. It was suggested that the 
translocation of methylmercury across the blood-brain barrier may be 
mediated by a neutral amino acid carrier transport system {121). In the 
present study, the cysteine treated group did exhibit a higher 
concentration of methylmercury in the brain tissue which may lend 
support to this theory. Another possible explanation for the results 
shown in the cysteine treated group is the oxidation/reduction theory 
suggested for the vitamin C treated groups. Cysteine is also easily 
oxidized and, in fact, prefers the oxidized state. Consequently, 
mercury exposure may result in the oxidation of cysteine and the 
reduction of mercuric to mercurous. As suggested earlier, the mercurous 
form is not as toxic to mammals or it may be methylated by 
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N5-methyltetrahydrofolate since it can accept a free radical methyl 
group. Certainly, this requires further research to elucidate the role 
of cysteine in the methylation of mercury. 
In conclusion, the results presented here generally support the 
concept that dietary intake of megadoses of vitamin 812 , folate, and/or 
vitamin C can alter the methylation, i.e. metabolism of inorganic 
mercury. While ingestion of megadoses of all three vitamins resulted in 
decreased mercury concentrations in all tissues except heart and lung, 
individual vitamins or a combination of vitamins consumed in megadoses 
resulted in increased methylmercury concentrations. Furthermore, the 
ABR testing provided additional evidence that mercury can result in 
neurological alterations and these can be influenced by a dietary 
vitamin intake. In addition, dietary supplementation with the sulfur 
containing amino acids, methionine and cysteine, may effect this 
methylation process. 
Factors which can alter the methylation process of mercury in vivo 
may have practical significance. For instance, in those geographical 
areas where there is a relatively high consumption of foods contaminated 
by mercury, the toxic effects of mercury ingestion may be significantly 
enhanced in those individuals who supplement their diets with vitamins. 
In addition, those individuals in the dental profession who may be 
frequently exposed to mercury compounds used in dental amalgams should 
become aware of the possibility that megavitamin consumption may 
potentiate the methylation process of mercury. Thus, further research 
is needed in this area and dissemination of this information via 
educational programs is necessary. 
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CHAPTER VI 
SUMMARY 
Ingestion of megadoses of certain vitamins appears to influence the 
methylation of mercuric chloride in vivo. The increased concentration 
of methylmercury and percent methylmercury values exhibited in the brain 
tissue with dietary consumption of vitamin 812 supports the hypothesis 
that this vitamin is involved in methylating mercury and, thus, allowing 
the transport of methylmercury across the blood-brain barrier. In 
addition, auditory brainstem response measurements showed that 812 
treated animals displayed delayed wave I latencies and higher threshold 
values compared to untreated controls and mercury only animals. This 
again suggests that this vitamin effects the methylation process. 
The incorporation of high levels of folate into the diet also 
influences mercury methylation. Folate treated animals tended to have 
increased concentrations of both inorganic and methylmercury, 
particularly in the muscle tissue. Animals given 812/folate and 
mercuric chloride also exhibited increased A8R wave amplitudes at the 
lower frequencies compared to the mercury only group. Further research 
is needed to determine the exact mechanism involved by which folate is 
able to methylate mercury. 
The addition of vitamin C in the diet, particularly in combination 
with 812 and/or folate, resulted in increased methylmercury levels and 
percent methylmercury values in the muscle, brain, and hair. An 
apparent synergistic effect was observed with vitamin C and the other 
vitamins. It has been suggested that vitamin C may play a role in the 
111 
re-methylation process of B12 by donating an electron to the methyl 
group contributed by folate. Alternately, the mercuric form of mercury 
may oxidize vitamin C and be subsequently reduced to the mercurous ion. 
This form is less toxic but may also be methylated by folate eliminating 
the involvement of B12 • The vitamin C group provided interesting ABR 
information. This group exhibited higher threshold measurements 
compared to controls and interpeak latencies were significantly shorter 
with vitamin C treatment. Certainly, further work is necessary to 
examine these possible interactions. 
And finally, diets supplemented with the amino acids cysteine and 
methionine indicated that these nutrients may also be involved in the 
methylation process of mercury. The increase in percent methylmercury 
levels found in the hepatic and renal tissues of rats is possibly due to 
the role of methionine in various methylation activities via S-
adenosylmethionine. Contrary to the research which has shown that 
cysteine inhibits certain reactions involving SAM, the animals treated 
with cysteine exhibited increased percent methyl levels in the liver, 
brain, heart, spleen and kidney tissues. Therefore, it would appear 
that cysteine effects mercury metabolism possibly via 
oxidation/reduction reactions. Again, this is an area requiring 
additional investigation. 
In conclusion, the methylation of mercuric chloride in vivo can be 
increased with the ingestion of megadoses of vitamin 812 , folate, or 
vitamin C. Therefore, individuals who take large amounts of these 
nutritional supplements and who ingest fish which are possibly 
contaminated with industrial spills containing mercury, could have 
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increased methylmercury exposure with subsequent neurological damage. 
Additionally, dental professionals should become aware of this 
potential. Further research is required to elucidate these effects and 
the possible mechanisms which are involved in the methylation of mercury 
in vivo. 
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APPENDIXES 
APPENDIX 1 
Table 1-1. Weight Data 
Week Controls 812/Folate 
1 243.79 ± 17.84 242.52 ± 2.74 
2 279.31 ± 33.11 290.81 ± 14.01 
3 326.01 ± 32.82 356.49 ± 22.76 
4 364.02 ± 41.48 393.70 ± 38.19 
5 424.69 ± 49.52 441.33 ± 52.10 
6 476.85 ± 54.96 481. 03 ± 73. 64 
7 518.68 ± 50.79 520.61 ± 79.50 
8 570.87 ± 56.03 567.09 ± 83.74 
*9 610.92 ± 56.45 605.36 ± 84.93 
10 633.61 ± 57.49 606.80 ± 93.90 
11 540.95 ± 54.55 560.55 ± 91.14 
Measurements represent the average± S.D. 
*Mercury injections were begun on week #9. 
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APPENDI.X 2 
Table 2-1. Frequency Means for Untreated Controls by Individual 
Intensities 
I I II II V V I-V 
Intensity Lat Amp Lat Amp Lat Amp IPL 
(dB) (msec) (µ V) (msec) (µ V) (msec) (µ V) (msec) 
8K 
105 1.31 1.54 2.13 l. ll 3.59 1.40 2.28 
95 1.43 1.23 2.25 .76 3.64 1.10 2.21 
85 1.58 1.09 2.37 .47 3.79 .69 2.21 
75 1.62 .90 2.51 .33 3.95 .34 2.33 
65 1. 72 .72 2.59 .28 4.13 .20 2.41 
55 1.85 .28 2. 77 .13 4.57 .12 2.70 
6K 
105 1.36 1.56 2.22 1.08 3.79 1.16 2.43 
95 1. 51 .88 2.37 .59 3.81 .82 2.29 
85 1.65 .68 2.51 .25 3.91 .50 2.26 
75 1. 74 .66 2.59 .23 4.06 .25 2.32 
65 1. 95 .42 2.83 .18 4.33 .15 2.38 
55 2 .13 .20 3.12 .09 4.62 .10 2.53 
4K 
105 1.48 2.01 2.34 1.48 4.05 1. 03 2.57 
95 1.61 1.24 2.51 .83 4.03 . 77 2.42 
85 1. 75 .70 2.60 .41 4.05 . 61 2.30 
75 1.87 .53 2.72 .19 4.17 .37 2.30 
65 2.04 .46 2.89 .20 4.42 .19 2.39 
55 2.20 .33 3.12 .12 4.61 .14 2.51 
2K 
105 1.87 1.25 2.80 .92 4.41 .70 2.55 
95 2.01 .76 2.88 .39 4.34 .31 2.37 
85 2.15 .49 3.08 .24 4.39 .28 2.21 
75 2.37 .33 3.26 .26 4.66 .25 2.27 
65 2.51 .23 3.52 .13 4.93 .20 2.42 
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Table 2-2. Frequency Means for Mercury Only Animals by Individual 
Intensities 
I I II II V V 1-V 
Intensity Lat Amp Lat Amp Lat Amp IPL 
(dB} (msec} (µV) (msec} (µV) (msec} (µV) (msec} 
BK 
105 1.28 1.08 2.12 .88 3.62 .83 2.34 
95 1.39 1.11 2.23 .82 3.85 .86 2.46 
85 1.47 1.05 2.36 .57 3.76 .54 2.29 
75 1.59 .91 2.47 .39 3.97 .17 2.38 
65 1. 72 .65 2.62 .19 4.29 .11 2.56 
55 1.83 .32 2.79 .15 4.35 .09 2.53 
6K 
105 1.34 .97 2.18 .85 3.80 .53 2.47 
95 1.50 .64 2.48 .38 3.82 .38 2.32 
85 1.62 . 71 2.58 .25 3.98 .14 2.36 
75 1. 73 .64 2. 71 .24 4 .10 .27 2.36 
65 1.85 .67 2.82 .19 4.52 .20 2.68 
55 2.03 .20 2.88 .16 4.77 .19 2.71 
4K 
105 1. 41 1.80 2.29 1. 79 3.93 .64 2.52 
95 1.59 .76 2.43 .69 4.12 .39 2.53 
85 1. 76 .51 2.75 .28 3.96 .47 2.23 
75 1.83 .42 2.73 .18 4.26 .22 2.43 
65 1. 98 .31 2.90 .24 4.52 .13 2.55 
55 2.22 .20 3 .18 .05 4.74 .08 2.52 
2K 
105 1.84 .96 2.75 1.01 4.52 .27 2.68 
95 1. 97 .55 2.94 .34 4.59 .11 2.61 
85 2 .16 .37 3.09 .24 4.49 .15 2.28 
75 2.42 .24 3.29 .12 4.60 .19 2 .18 
65 2.55 .17 3.61 .15 4.96 .12 2.40 
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Table 2-3. Frequency Means for B12 Treated Animals by Individual 
Intensities 
I I II II V V I-V 
Intensity Lat Amp Lat Amp Lat Amp IPL 
(dB) (msec) (µV) (msec) (µV) (msec) (µV) (msec) 
BK 
105 1.43 1.29 2.23 .80 3.62 1.45 2.20 
95 1.56 1.08 2.37 .56 3.78 1.02 2.22 
85 1.68 .85 2.55 .33 3.98 .53 2.30 
75 1.90 .75 2.50 .30 4.02 .37 2.12 
65 1.80 .52 2.75 .07 4.24 .12 2.44 
55 1.86 .17 
6K 
105 1.54 1. 21 2.37 .88 3.85 1.06 2.31 
95 1.67 .66 2.49 .44 3.76 .92 2.17 
85 1. 75 .60 2.61 .17 4.00 .43 2.25 
75 1.81 .76 2.57 .39 4.02 .29 2.21 
65 1. 95 .41 2.90 .18 4.29 .15 2.34 
55 2 .12 .12 
4K 
105 1.64 1.27 2.51 .78 4.00 .86 2.36 
95 1. 79 .83 2.65 .49 4.02 .53 2.23 
85 1.99 .48 2.88 .24 4.07 .63 2.17 
75 1.88 .63 2.75 .28 4.01 .56 2.13 
65 2.07 .49 2.91 .15 4.18 .22 2 .11 
55 2 .18 .29 3.08 .26 4.57 .08 2.39 
2K 
105 2.07 .76 2.87 .69 4.27 .39 2.14 
95 2.30 .58 3.03 .38 4.47 .34 2.06 
85 2.33 .48 2.93 .36 4.42 .31 2.09 
75 2.38 .31 4.47 .27 2.09 
65 2.70 .19 4.69 .18 2.08 
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Table 2-4. Frequency Means for Folate Treated Animals by Individual 
Intensities 
I I II II V V I-V 
Intensity Lat Amp Lat Amp Lat Amp IPL 
{dB) (msec) {uV) (msec) {µV) {msec) (µ V) {msec) 
8K 
105 1.28 1.17 2.18 1.01 3.57 I. 01 2.29 
95 1.38 1.05 2.28 .97 3.67 .86 2.29 
85 1.48 .93 2.39 .68 3.80 .45 2.32 
75 1.61 .73 2.52 .39 4.02 .18 2.41 
65 I. 79 .44 2.64 .26 4.37 .10 2.59 
55 1.87 .19 2.78 .12 
6K 
105 1.34 1.28 2.25 I. 20 3.75 .93 2.40 
95 1.49 .73 2.37 .69 3.79 .70 2.30 
85 1.61 .50 2.50 .29 3.88 .49 2.23 
75 I. 76 .48 2.70 .23 4.20 .21 2.45 
65 1.88 .40 2.86 .14 4.35 .09 2.45 
55 I. 90 .24 4.54 .12 2.64 
4K 
105 1.45 2.02 2.35 I. 93 3.98 .96 2.54 
95 1.58 1.13 2.48 .90 3.95 .72 2.37 
85 I. 70 .55 2.59 .41 4.05 .47 2.35 
75 1.83 .52 2.73 .33 4.06 .35 2.23 
65 1.99 .42 2.96 .25 4.23 .19 2.25 
55 2 .15 .24 3.00 .14 4.47 .12 2.32 
2K 
105 1.84 1.02 2.75 1.10 4.30 .71 2.46 
95 1.98 .79 2.80 .89 4.42 .36 2.44 
85 2.12 .41 3.07 .19 4.45 .26 2.32 
75 2.41 .29 l.22 .13 4.68 .24 2.27 
65 2.40 .19 4.70 .14 2.30 
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Table 2-5. Frequency Means for Vitamin C Treated Animals by Individual 
Intensities 
I I II II V V I-V 
Intensity Lat Amp Lat Amp Lat Amp IPL 
{dB) (msec) (µV) (msec) (µV) (msec) (µV) (msec) 
BK 
105 1.33 1.41 2 .18 .79 3.50 1.48 2.17 
95 1.46 1. 22 2.29 .43 3.60 1.22 2.14 
85 1. 57 1.12 2.43 .36 3.75 .73 2.18 
75 1.68 .89 2.52 .27 3.93 .34 2.25 
65 1.82 .48 2.60 .12 4.30 .14 2.48 
55 1. 91 .15 4.72 .12 2.74 
6K 
105 1.42 I.OS 2.27 .59 3.66 1. 20 2.24 
95 1.59 .82 2.31 .59 3.72 .89 2.13 
85 1. 72 .64 2.54 .18 3.83 .41 2 .11 
75 1.88 .47 2.63 .23 4 .16 .16 2.27 
65 1.93 .37 2.77 .14 4.35 .11 2.39 
55 2.00 .12 2.84 .09 4.20 .09 2.20 
4K 
105 1.46 1.47 2.34 .85 3.82 .87 2.36 
95 1.61 .99 2.48 .86 .89 .92 2.28 
85 1.83 .52 2.52 .38 3.93 .70 2.10 
75 1. 94 .39 2.66 .16 4.08 .29 2.13 
65 2.09 .28 2.87 .10 4.38 .12 2.32 
55 2.16 .17 2.90 .02 4.49 .08 2.33 
2K 
105 1.90 .79 2.69 .46 4.28 .47 2.37 
95 2.04 .56 3.06 .25 4.23 .33 2.17 
85 2.30 ~33 3.20 .12 4.44 .25 2.14 
75 2.45 .25 3.34 .08 4.52 .25 2.02 
65 2.60 .14 4.52 .12 1. 91 
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Table 2-6. Frequency Means for 812/Folate Treated Animals by 
Individual Intensities 
I I II II V V 1-V 
Intensity Lat Amp Lat Amp Lat Amp IPL 
{dB} (msec} {µ V} (msec} (µV} (msec} (µ V} (msec} 
BK 
105 1.22 1.63 2.12 1.34 3.58 1.48 2.36 
95 1.36 1.26 2.23 .73 3.61 1.17 2.24 
85 1.44 1.18 2.30 .61 3. 72 .95 2.28 
75 1.56 1.10 2.44 .43 3.91 .45 2.35 
65 1.66 .77 2.63 .19 4.09 .22 2.44 
55 1.81 .33 2.74 .14 4.62 .14 2.81 
6K 
105 1.32 1.45 2.23 1.31 3.81 1.07 2.49 
95 1.48 .81 2.40 .60 3.81 .94 2.33 
85 1.59 .79 2.50 .30 4.07 .48 2.48 
75 1. 72 .75 2.64 .31 4.23 .28 2.51 
65 2.05 .41 2.92 .30 4.62 .24 2.57 
55 2.05 .20 3.08 .15 4.62 .12 2.60 
4K 
105 1.41 2.43 2.32 2.30 3.94 1.47 2.53 
95 1.53 1.29 2.44 1.03 3.93 .65 2.40 
85 1.64 .87 2.56 .49 3.95 .76 2.31 
75 1. 78 .74 2. 71 .28 4.04 .52 2.26 
65 1. 96 .56 2.89 .16 4.36 .25 2.39 
55 2.22 .40 3 .14 .17 4.52 .17 2.30 
2K 
105 1. 76 1.32 2.76 1.07 4.36 .82 2.61 
95 1.89 .93 2.84 .42 4.19 .38 2.30 
85 2.05 .59 2.98 .40 4.31 .32 2.24 
75 2.24 .42 3.20 .34 4.48 .27 2.23 
65 2.48 .23 3.61 .27 4.86 .16 2.29 
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